FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

Dirk van Veldhuisen

Research Profile

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Ventricular Function, Left

Geographic Areas

Netherlands

Procedures

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Mihai Gheorghiade; Kanan Patel; Dirk J van Veldhuisen; Inmaculada B Aban; Stefan D Anker; Wilbert S Aronow; Javed Butler; John G F Cleland; Andrew E Epstein; Gregg C Fonarow; Ali Ahmed
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J.L. Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
Mihai Gheorghiade; Stephen J Greene; John J V McMurray; Marco Metra; Kanan Patel; Dirk J van Veldhuisen; Inmaculada B Aban; Kirkwood F Adams; Stefan D Anker; John G F Cleland; Gerasimos Filippatos; Ali Ahmed
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of Dirk van Veldhuisen (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2013: Mihai Gheorghiade; Kanan Patel; Dirk J van Veldhuisen; Inmaculada B Aban; Stefan D Anker; Wilbert S Aronow; Javed Butler; John G F Cleland; Andrew E Epstein; Gregg C Fonarow; Ali Ahmed
Lack of evidence of increased mortality among patients with atrial fibrillation taking digoxin: findings from post hoc propensity-matched analysis of the AFFIRM trial.
European heart journal 2013;34(20):1489-97.
2013: Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Pim van der Harst; Dirk J van Veldhuisen; Adriaan A Voors; Stephan J.L. Bakker; Wiek H van Gilst
Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND.
European heart journal 2013;34(19):1424-31.
2013: Mihai Gheorghiade; Stephen J Greene; John J V McMurray; Marco Metra; Kanan Patel; Dirk J van Veldhuisen; Inmaculada B Aban; Kirkwood F Adams; Stefan D Anker; John G F Cleland; Gerasimos Filippatos; Ali Ahmed
Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial.
European journal of heart failure 2013;15(5):551-9.
2013: Dirk J van Veldhuisen; Isabelle C Van Gelder; Ali Ahmed; Mihai Gheorghiade
Digoxin for patients with atrial fibrillation and heart failure: paradise lost or not?
European heart journal 2013;34(20):1468-70.
2013: Dirk J van Veldhuisen; Adriaan A Voors; Arno W Hoes; Tiny Jaarsma; Gerard C M Linssen; Walter J Paulus; Jan G P Tijssen; Wiek H van Gilst; Hans L Hillege
B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction.
Journal of the American College of Cardiology 2013;61(14):1498-506.
2013: Ijsbrand T Klip; Dirk J Lok; Lech Polonski; Piotr Ponikowski; Piotr Rosentryt; Ainhoa Torrens; Peter van der Meer; Dirk J van Veldhuisen; Adriaan A Voors; Waldemar Banasiak; Josep Comin-Colet; Cristina Enjuanes; Ewa A Jankowska
Iron deficiency in chronic heart failure: an international pooled analysis.
American heart journal 2013;165(4):575-582.e3.
2013: H F Groenveld; Hans L Hillege; J G P Tijssen; Y S Tuininga; Maarten P van den Berg; M Alings; H J G M Crijns; Dirk J van Veldhuisen; I C Van Gelder
Rate control in atrial fibrillation, insight into the RACE II study.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2013;21(4):199-204.
2013: Karl Swedberg; Michal Tendera; Dirk J van Veldhuisen; James B Young; Inder S Anand; Sunfa Cheng; Akshay S Desai; Rafael Diaz; Aldo P Maggioni; John J V McMurray; Christopher O'Connor; Marc A Pfeffer; Scott D Solomon; Yan Sun
Treatment of anemia with darbepoetin alfa in systolic heart failure.
The New England journal of medicine 2013;368(13):1210-9.
2013: Peter Johansson; Ivonne Lesman-Leegte; Johan Lundgren; Robbert Sanderman; Dirk J van Veldhuisen; Hans L Hillege; Arno Hoes; Tiny Jaarsma
Time-course of depressive symptoms in patients with heart failure.
Journal of psychosomatic research 2013;74(3):238-43.
2013: A Rogier van der Velde; Dirk J van Veldhuisen; Aram Adourian; Pål Aukrust; Lars Gullestad; Yu Guo; Pieter Muntendam; Thor Ueland; Rudolf A de Boer
Prognostic value of changes in galectin-3 levels over time in patients with heart failure: data from CORONA and COACH.
Circulation. Heart failure 2013;6(2):219-26.
2013: Niek Verweij; Hongjuan Yu; Wiek H van Gilst; Dirk J van Veldhuisen; Folkert W Asselbergs; Stephan J L Bakker; Frank P Brouwers; Rudolf A de Boer; Ron T Gansevoort; Hans L Hillege; Hasan Mahmud; Irene Mateo Leach; Patricia B Munroe; Herman H W Silljé; Joachim Struck; Pim van der Harst
Genome-wide association study on plasma levels of midregional-proadrenomedullin and C-terminal-pro-endothelin-1.
Hypertension 2013;61(3):602-8.
2013: John J V McMurray; Christopher O'Connor; Marc A Pfeffer; Debra Scarlata; Scott D Solomon; Karl Swedberg; Michal Tendera; Dirk J van Veldhuisen; James B Young; Moetaz Albizem; Inder S Anand; Sunfa Cheng; Rafael Diaz; Aldo P Maggioni
Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF).
European journal of heart failure 2013;15(3):334-41.
2013: Hessel F Groenveld; Hans L Hillege; Jan G P Tijssen; Maarten P van den Berg; Isabelle C Van Gelder; Dirk J van Veldhuisen; Marco Alings; Harry J G M Crijns
Rate control efficacy in permanent atrial fibrillation: successful and failed strict rate control against a background of lenient rate control: data from RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation).
Journal of the American College of Cardiology 2013;61(7):741-8.
2013: Dirk J Lok; Sjoukje I Lok; Dirk J van Veldhuisen; Jan van Wijngaarden; Erik Badings; Pieta W Bruggink-André de la Porte; Rudolf A de Boer; Eric Lipsic; Peter van der Meer
Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2013;102(2):103-10.
2013: Daniela Dobre; Henry Krum; Zohra Lamiral; Jan Murin; Alexander Parkhomenko; Bertram Pitt; Patrick Rossignol; Dirk J van Veldhuisen; Faiez Zannad
Statin therapy and clinical outcomes in myocardial infarction patients complicated by acute heart failure: insights from the EPHESUS trial.
European journal of heart failure 2013;15(2):221-7.
2013: Hendrik G Freling; Petronella G Pieper; Paul E Sijens; Jeroen M van Swieten; Dirk J van Veldhuisen; Karin M Vermeulen; Tineke P Willems
Improved cardiac MRI volume measurements in patients with tetralogy of Fallot by independent end-systolic and end-diastolic phase selection.
PloS one 2013;8(1):e55462.
2013: Lili Yu; Ruud A Bank; Eelke M. Bos; Irwin J Goldstein; Jasper A Koerts; Maxi Meissner; Bertram Pitt; Willem P T Ruifrok; Bahram Sanjabi; Herman H W Silljé; Pim van der Harst; Wiek H van Gilst; Harry van Goor; Dirk J van Veldhuisen; Rudolf A de Boer
Genetic and pharmacological inhibition of galectin-3 prevents cardiac remodeling by interfering with myocardial fibrogenesis.
Circulation. Heart failure 2013;6(1):107-17.
2013: Dirk J van Veldhuisen; John J V McMurray
Pharmacological treatment of heart failure with preserved ejection fraction: a glimpse of light at the end of the tunnel?
European journal of heart failure 2013;15(1):5-8.
2013: Tialda Hoekstra; Tiny Jaarsma; Robbert Sanderman; Dirk J van Veldhuisen; Hans L Hillege; Ivonne Lesman-Leegte
Quality of life and survival in patients with heart failure.
European journal of heart failure 2013;15(1):94-102.
2012: Frank P Brouwers; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Comparing new onset heart failure with reduced ejection fraction and new onset heart failure with preserved ejection fraction: an epidemiologic perspective.
Current heart failure reports 2012;9(4):363-8.
2012: I H Kraai; M L A Luttik; Dirk J van Veldhuisen; R M De Jong; H L Hillege; P Johansson; Tiny Jaarsma
Health-related quality of life and anemia in hospitalized patients with heart failure.
International journal of cardiology 2012;161(3):151-5.
2012: Jennifer K Rogers; Harry Shi; Karl Swedberg; Dirk J van Veldhuisen; John Vincent; Faiez Zannad; Henry Krum; John J V McMurray; Stuart J Pocock; Bertram Pitt
Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations.
Circulation 2012;126(19):2317-23.
2012: Suzan Willemsen; Jasper W L Hartog; Hans L Hillege; Tiny Jaarsma; Joline F Roze; Casper Schalkwijk; Iwan C C van der Horst; Peter van der Meer; Dirk J van Veldhuisen; Adriaan A Voors
The role of advanced glycation end-products and their receptor on outcome in heart failure patients with preserved and reduced ejection fraction.
American heart journal 2012;164(5):742-749.e3.
2012: Tialda Hoekstra; Ivonne Lesman-Leegte; Marie Louise Luttik; Robbert Sanderman; Dirk J van Veldhuisen; Tiny Jaarsma
Sexual problems in elderly male and female patients with heart failure.
Heart (British Cardiac Society) 2012;98(22):1647-52.
2012: Yoran M Hummel; Marco Metra; Johannes S Sipkens; Dirk J van Veldhuisen; Silvia Bugatti; Kevin Damman; Jasper W L Hartog; Suzan Willemsen; Adriaan A Voors
Functional and hemodynamic cardiac determinants of exercise capacity in patients with systolic heart failure.
The American journal of cardiology 2012;110(9):1336-41.
2012: Thomas F Lüscher; Frank Ruschitzka; Wiek H van Gilst; Ulf Landmesser; Adriaan A Voors; Dirk J van Veldhuisen
The European Heart Journal and the European Journal of Heart Failure: partners in scientific publishing.
European journal of heart failure 2012;14(10):1075-82.
2012: Bart A Mulder; Michael Roughton; Dirk J van Veldhuisen; Daphne Babalis; Michael Böhm; Andrew J S Coats; Alain Cohen-Solal; Harry J G M Crijns; Marcus D Flather; Isabelle C Van Gelder
Effect of nebivolol on outcome in elderly patients with heart failure and atrial fibrillation: insights from SENIORS.
European journal of heart failure 2012;14(10):1171-8.
2012: Adriaan A Voors; Dirk J van Veldhuisen
Why do drugs for acute heart failure fail?
European journal of heart failure 2012;14(9):955-6.
2012: Rudolf A de Boer; Ron T Gansevoort; Stephan J L Bakker; Hasan Mahmud; Nicolas F Schroten; Mariusz K Szymanski; Pim van der Harst; Wiek H van Gilst; Dirk J van Veldhuisen; Hans L Hillege
Plasma renin and outcome in the community: data from PREVEND.
European heart journal 2012;33(18):2351-9.
2012: Marcelle D Smit; Peter P van Geel; Dirk J van Veldhuisen; Ismaël D Achekar; Hans L Hillege; Alexander H Maass; Marjolein L Moes; Isabelle C Van Gelder
The importance of whether atrial fibrillation or heart failure develops first.
European journal of heart failure 2012;14(9):1030-40.
2012: Lars Gullestad; Johannes Hulthe; John Kjekshus; Michel Komajda; John J V McMurray; Pieter Muntendam; Ståle H Nymo; Thor Ueland; Dirk J van Veldhuisen; John Wikstrand; Aram Adourian; Pål Aukrust; Michael Böhm; John G F Cleland
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA).
European heart journal 2012;33(18):2290-6.
2012: Maria Rosa Costanzo; Hamlet Hayrapetyan; Lee Henderson; J Thomas Heywood; Julie Iwashita; Merab Mamatsashvili; Barry M Massie; Philip Sager; Hamayak Sisakian; Dirk J van Veldhuisen; Detlef Albrecht
A double-blind, randomized, parallel, placebo-controlled study examining the effect of cross-linked polyelectrolyte in heart failure patients with chronic kidney disease.
European journal of heart failure 2012;14(8):922-30.
2012: David Preiss; Naveed Sattar; Harry Shi; Karl Swedberg; Dirk J van Veldhuisen; John Vincent; Faiez Zannad; Henry Krum; Bertram Pitt; Stuart J Pocock; John J V McMurray
Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF).
European journal of heart failure 2012;14(8):909-15.
2012: Marie Louise Luttik; M Berger; M Brons; R de Jong; Hans L Hillege; A Hoes; Tiny Jaarsma; G Linssen; D J Lok; Dirk J van Veldhuisen
Design and methodology of the COACH-2 (Comparative study on guideline adherence and patient compliance in heart failure patients) study: HF clinics versus primary care in stable patients on optimal therapy.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2012;20(7-8):307-12.
2012: M M W Nieuwenhuis; Tiny Jaarsma; Dirk J van Veldhuisen; M H L van der Wal
Self-reported versus 'true' adherence in heart failure patients: a study using the Medication Event Monitoring System.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2012;20(7-8):313-9.
2012: Iain C Macdougall; Piotr Ponikowski; Donald Silverberg; Dirk J van Veldhuisen; Bernard CANAUD; Angel L M de Francisco; Gerasimos Filippatos; Stefan D Anker
Beyond the cardiorenal anaemia syndrome: recognizing the role of iron deficiency.
European journal of heart failure 2012;14(8):882-6.
2012: Maurice M W Nieuwenhuis; Douwe Postmus; Tiny Jaarsma; Dirk J van Veldhuisen; Martje H L van der Wal
Long-term compliance with nonpharmacologic treatment of patients with heart failure.
The American journal of cardiology 2012;110(3):392-7.
2012: Dirk J van Veldhuisen; Alexander H Maass
Telemonitoring of outpatients with heart failure: a search for the holy grail?
Circulation 2012;125(24):2965-7.
2012: Paul J Hauptman; Martin Borggrefe; Michael R Gold; Peter J Schwartz; Randall C Starling; Dirk J van Veldhuisen; Douglas L Mann
Rationale and study design of the increase of vagal tone in heart failure study: INOVATE-HF.
American heart journal 2012;163(6):954-962.e1.
2012: Marcelle D Smit; Anne Margreet De Jong; Alexander H Maass; Anneke C Muller Kobold; Dirk J van Veldhuisen; Isabelle C Van Gelder
Role of inflammation in early atrial fibrillation recurrence.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2012;14(6):810-7.
2012: Karl Swedberg; Dirk J van Veldhuisen; John Vincent; Faiez Zannad; Henry Krum; John J V McMurray; Bertram Pitt; Harry Shi
Eplerenone and atrial fibrillation in mild systolic heart failure: results from the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) study.
Journal of the American College of Cardiology 2012;59(18):1598-603.
2012: Peter Johansson; Martje van der Wal; Dirk J van Veldhuisen; Tiny Jaarsma
Association between prehospital delay and subsequent clinical course in patients with/hospitalized for heart failure.
Journal of cardiac failure 2012;18(3):202-7.
2012: M K Szymanski; J van der Velden; Dirk J van Veldhuisen; J H Buikema; N Hamdani; J L Hillege; J Koster; Regien G Schoemaker
Increased cardiovascular risk in rats with primary renal dysfunction; mediating role for vascular endothelial function.
Basic research in cardiology 2012;107(2):242.
2012: Nicolas F Schroten; Mariusz K Szymanski; Dirk J van Veldhuisen; Carlo A J M Gaillard; Hans L Hillege; Rudolf A de Boer
New roles for renin and prorenin in heart failure and cardiorenal crosstalk.
Heart failure reviews 2012;17(2):191-201.
2012: Kevin Damman; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors; Hans L Hillege
Current and novel renal biomarkers in heart failure.
Heart failure reviews 2012;17(2):241-50.
2012: Steef J Sinkeler; Dirk J van Veldhuisen; Kevin Damman; Hans Hillege; gerjan navis
A re-appraisal of volume status and renal function impairment in chronic heart failure: combined effects of pre-renal failure and venous congestion on renal function.
Heart failure reviews 2012;17(2):263-70.
2012: Suzan Willemsen; Jasper W L Hartog; M Rebecca Heiner-Fokkema; Dirk J van Veldhuisen; Adriaan A Voors
Advanced glycation end-products, a pathophysiological pathway in the cardiorenal syndrome.
Heart failure reviews 2012;17(2):221-8.
2012: Tialda Hoekstra; Tiny Jaarsma; Robbert Sanderman; Dirk J van Veldhuisen; Ivonne Lesman-Leegte
Perceived sexual difficulties and associated factors in patients with heart failure.
American heart journal 2012;163(2):246-51.
2012: Douwe Postmus; Dirk J van Veldhuisen; Erik Buskens; Veli-Pekka Harjola; Tiny Jaarsma; Johan Lassus; James Lewsey; Marie Louise Luttik; Alexandre Mebazaa; Markku S Nieminen; Hans L Hillege
The COACH risk engine: a multistate model for predicting survival and hospitalization in patients with heart failure.
European journal of heart failure 2012;14(2):168-75.
2012: Kevin Damman; gerjan navis; Tom D J Smilde; Pim van der Harst; Dirk J van Veldhuisen; Adriaan Voors; Hans L Hillege
Use of cystatin C levels in estimating renal function and prognosis in patients with chronic systolic heart failure.
Heart (British Cardiac Society) 2012;98(4):319-24.
2012: Rudolf A de Boer; Lude Franke; Ron T Gansevoort; Irene Mateo Leach; Anneke C Muller Kobold; Wiek H van Gilst; Dirk J van Veldhuisen; Niek Verweij; Harm-Jan Westra; Stephan J L Bakker; Pim van der Harst
A genome-wide association study of circulating galectin-3.
PloS one 2012;7(10):e47385.
2012: Nigussie Bogale; Josep Brugada; Laszlo Buga; John G F Cleland; Geneviève Derumeaux; Kenneth Dickstein; Fredrik Gadler; Maurizio Gasparini; Anselm Gitt; Daniel Gras; Tobias Limbourg; Cecilia Linde; Marco Metra; Silvia Priori; Christoph Stellbrink; Dirk J van Veldhuisen; Angelo Auricchio
The European CRT Survey: 1 year (9-15 months) follow-up results.
European journal of heart failure 2012;14(1):61-73.
2011: Douwe Postmus; Dirk J van Veldhuisen; Anees A Abdul Pari; Hans L Hillege; Tiny Jaarsma; Marie Louise Luttik; Erik Buskens
A trial-based economic evaluation of 2 nurse-led disease management programs in heart failure.
American heart journal 2011;162(6):1096-104.
2011: Youlan L Gu; Hans L Hillege; Serge Masson; Joachim Struck; Tarcisio Vago; Ad F M van den Heuvel; Dirk J van Veldhuisen; Adriaan A Voors; Felix Zijlstra; Stefan D Anker; Bart J G L de Smet
Comparison of the temporal release pattern of copeptin with conventional biomarkers in acute myocardial infarction.
Clinical research in cardiology : official journal of the German Cardiac Society 2011;100(12):1069-76.
2011: Kevin Damman; Hans L Hillege; Franco Cosmi; Aldo P Maggioni; Serge Masson; Laura Montagna; Cristina Opasich; Luigi Tavazzi; Gianni Tognoni; Dirk J van Veldhuisen; Adriaan Voors; Roberto Latini
Clinical outcome of renal tubular damage in chronic heart failure.
European heart journal 2011;32(21):2705-12.
2011: Hessel F Groenveld; Hans L Hillege; Adelita Ranchor; Jan G P Tijssen; Ype S Tuininga; Maarten P van den Berg; Isabelle C Van Gelder; Eric van Sonderen; Dirk J van Veldhuisen; A Marco Alings; Harry J G M Crijns
The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.
Journal of the American College of Cardiology 2011;58(17):1795-803.
2011: Dirk J van Veldhuisen; Cheuk-Man Yu; Roberto Muñoz Aguilera; Martin Borggrefe; Frieder Braunschweig; Viviane Conraads; Martin R Cowie; Ian Ford; Bart Gerritse; Guillaume Jondeau; Josef Kautzner; Maurizio Lunati
Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure.
Circulation 2011;124(16):1719-26.
2011: Gerard C M Linssen; Michiel Rienstra; Isabelle C Van Gelder; Hans L Hillege; Tiny Jaarsma; Adriaan A Voors; Dirk J van Veldhuisen
Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction.
European journal of heart failure 2011;13(10):1111-20.
2011: Mariusz K Szymanski; Wiek H van Gilst; Dirk J van Veldhuisen; Kevin Damman; Hans L Hillege; Rudolf A de Boer
Prognostic value of renin and prorenin in heart failure patients with decreased kidney function.
American heart journal 2011;162(3):487-93.
2011: Kevin Damman; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors; Hans L Hillege
The cardiorenal syndrome in heart failure.
Progress in cardiovascular diseases 2011;54(2):144-53.
2011: James C Coyne; Tiny Jaarsma; Marie Louise Luttik; Eric van Sonderen; Dirk J van Veldhuisen; Robbert Sanderman
Lack of prognostic value of type D personality for mortality in a large sample of heart failure patients.
Psychosomatic medicine 2011;73(7):557-62.
2011: Alexander H Maass; Dirk J van Veldhuisen
Remote monitoring via implanted devices in heart failure: rising star or lame duck?
European journal of heart failure 2011;13(9):925-6.
2011: Tialda Hoekstra; Ivonne Lesman-Leegte; Robbert Sanderman; Dirk J van Veldhuisen; Tiny Jaarsma
Quality of life is impaired similarly in heart failure patients with preserved and reduced ejection fraction.
European journal of heart failure 2011;13(9):1013-8.
2011: Dirk J van Veldhuisen; Piotr Ponikowski; Stefan D Anker; Iain C Macdougall
Anemia and iron deficiency in heart failure: mechanisms and therapeutic approaches.
Nature reviews. Cardiology 2011;8(9):485-93.
2011: Sheba Ahmed; Isabelle C Van Gelder; Dirk J van Veldhuisen; Ans C P Wiesfeld; Thera P Links
Determinants and outcome of amiodarone-associated thyroid dysfunction.
Clinical endocrinology 2011;75(3):388-94.
2011: Marcelle D Smit; Jan G P Tijssen; Ype S Tuininga; Maarten P van den Berg; Isabelle C Van Gelder; Dirk J van Veldhuisen; Marco Alings; Harry J G M Crijns; Hessel F Groenveld; Hans L Hillege
Effect of lenient versus strict rate control on cardiac remodeling in patients with atrial fibrillation data of the RACE II (RAte Control Efficacy in permanent atrial fibrillation II) study.
Journal of the American College of Cardiology 2011;58(9):942-9.
2011: Alan S Maisel; Christian Mueller; Robert Brikhan; Paul Clopton; Robert Fitzgerald; Brian C Hiestand; Navaid Iqbal; Dirk J van Veldhuisen
Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: the NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial.
European journal of heart failure 2011;13(8):846-51.
2011: Peter van der Meer; Dirk J van Veldhuisen
Acute coronary syndromes: the unfulfilled promise of erythropoietin in patients with MI.
Nature reviews. Cardiology 2011;8(8):425-6.
2011: Jasper W L Hartog; Hans L Hillege; Yoran M Hummel; Jan L Posma; Dirk J van Veldhuisen; LM van Wijk; Adriaan Voors; Suzan Willemsen
Effects of alagebrium, an advanced glycation endproduct breaker, on exercise tolerance and cardiac function in patients with chronic heart failure.
European journal of heart failure 2011;13(8):899-908.
2011: Erik Lipšic; Peter van der Meer; Dirk J van Veldhuisen
Erythropoiesis-stimulating agents and heart failure.
Cardiovascular therapeutics 2011;29(4):e52-9.
2011: Christian Funck-Brentano; Michael Goulder; Louis L M van de Ven; Dirk J van Veldhuisen; Ronnie Willenheimer; Ferenc Follath
Influence of order and type of drug (bisoprolol vs. enalapril) on outcome and adverse events in patients with chronic heart failure: a post hoc analysis of the CIBIS-III trial.
European journal of heart failure 2011;13(7):765-72.
2011: Frank P Brouwers; Folkert Asselbergs; Hans L Hillege; Rudolf A de Boer; Ron T Gansevoort; Dirk J van Veldhuisen; Wiek H van Gilst
Long-term effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria:Ten years of follow-up of Prevention of Renal and Vascular End-stage Disease Intervention Trial (PREVEND IT).
American heart journal 2011;161(6):1171-8.
2011: Peter Johansson; Ivonne Lesman-Leegte; Erland Svensson; Adriaan Voors; Dirk J van Veldhuisen; Tiny Jaarsma
Depressive symptoms and inflammation in patients hospitalized for heart failure.
American heart journal 2011;161(6):1053-9.
2011: Stephan von Haehling; Dirk J van Veldhuisen; Michael Roughton; Daphne Babalis; Rudolf A de Boer; Andrew J S Coats; Luis Manzano; Marcus Flather; Stefan D Anker
Anaemia among patients with heart failure and preserved or reduced ejection fraction: results from the SENIORS study.
European journal of heart failure 2011;13(6):656-63.
2011: Riemer H J A Slart; Clark J Zeebregts; Hans L Hillege; Johan de Sutter; Rudi A J O Dierckx; Dirk J van Veldhuisen; Felix Zijlstra; René A Tio
Myocardial perfusion reserve after a PET-driven revascularization procedure: a strong prognostic factor.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2011;52(6):873-9.
2011: Licette C Y Liu; Adriaan Voors; Dirk J van Veldhuisen; Eveline van der Veer; Anne M Belonje; Mariusz K Szymanski; Herman H W Silljé; Wiek H van Gilst; Tiny Jaarsma; Rudolf A de Boer
Vitamin D status and outcomes in heart failure patients.
European journal of heart failure 2011;13(6):619-25.
2011: Ijsbrand T Klip; Iain Squire; Joachim Struck; Dirk J van Veldhuisen; Adriaan Voors; Stefan D Anker; Kenneth Dickstein; Hans L Hillege
Prognostic value of mid-regional pro-adrenomedullin in patients with heart failure after an acute myocardial infarction.
Heart (British Cardiac Society) 2011;97(11):892-8.
2011: Kevin Damman; Marie J Ng Kam Chuen; Robert J MacFadyen; Gregory Y H Lip; David Gaze; Paul O Collinson; Hans L Hillege; Wim van Oeveren; Adriaan Voors; Dirk J van Veldhuisen
Volume status and diuretic therapy in systolic heart failure and the detection of early abnormalities in renal and tubular function.
Journal of the American College of Cardiology 2011;57(22):2233-41.
2011: Luis Manzano; Philip P A Poole-Wilson; Michael Roughton; Marcelo Shibata; Dirk J van Veldhuisen; Stefan D Anker; Daphne Babalis; Andrew J Coats; Alain Cohen-Solal; Marcus D Flather; Stefano Ghio
Predictors of clinical outcomes in elderly patients with heart failure.
European journal of heart failure 2011;13(5):528-36.
2011: Jardi Huzen; Wouter Peeters; Rudolf A de Boer; Frans L Moll; Liza S M Wong; Veryan Codd; Dominique P V de Kleijn; Bart J G L de Smet; Dirk J van Veldhuisen; Nilesh J Samani; Wiek H van Gilst; Gerard Pasterkamp; Pim van der Harst
Circulating leukocyte and carotid atherosclerotic plaque telomere length: interrelation, association with plaque characteristics, and restenosis after endarterectomy.
Arteriosclerosis, thrombosis, and vascular biology 2011;31(5):1219-25.
2011: Marcelle D Smit; Alexander H Maass; Hans L Hillege; Ans C P Wiesfeld; Dirk J van Veldhuisen; Isabelle C Van Gelder
Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy.
European journal of heart failure 2011;13(5):543-50.
2011: Peter van der Meer; Dirk J van Veldhuisen
To bind or not to bind: potassium-lowering drugs in heart failure.
European heart journal 2011;32(7):791-2.
2011: Willem-Peter T Ruifrok; Cheng Qian; Herman H W Silljé; Harry van Goor; Dirk J van Veldhuisen; Wiek H van Gilst; Rudolf A de Boer
Heart failure-associated anemia: bone marrow dysfunction and response to erythropoietin.
Journal of molecular medicine (Berlin, Germany) 2011;89(4):377-87.
2011: Anne Margreet De Jong; Alexander H Maass; Silke U Oberdorf-Maass; Dirk J van Veldhuisen; Wiek H van Gilst; Isabelle C Van Gelder
Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation.
Cardiovascular research 2011;89(4):754-65.
2011: Ali Balci; Willem Drenthen; Barbara J M Mulder; Jolien Roos-Hesselink; Adriaan A Voors; Hubert W Vliegen; Philip Moons; Krystyna M Sollie; Arie P J van Dijk; Dirk J van Veldhuisen; Petronella G Pieper
Pregnancy in women with corrected tetralogy of Fallot: occurrence and predictors of adverse events.
American heart journal 2011;161(2):307-13.
2011: Ali Balci; Krystyna M Sollie; Barbara J M Mulder; Monique W M de Laat; Jolien Roos-Hesselink; Arie P J van Dijk; Elly M C J Wajon; Hubert W Vliegen; Willem Drenthen; Hans L Hillege; Jan G Aarnoudse; Dirk J van Veldhuisen; Petronella G Pieper
Associations between cardiovascular parameters and uteroplacental Doppler (blood) flow patterns during pregnancy in women with congenital heart disease: Rationale and design of the Zwangerschap bij Aangeboren Hartafwijking (ZAHARA) II study.
American heart journal 2011;161(2):269-275.e1.
2011: Rudolf A de Boer; Dirk J A Lok; Tiny Jaarsma; Peter van der Meer; Adriaan A Voors; Hans L Hillege; Dirk J van Veldhuisen
Predictive value of plasma galectin-3 levels in heart failure with reduced and preserved ejection fraction.
Annals of medicine 2011;43(1):60-8.
2011: Alexander H Maass; Dirk J van Veldhuisen
Heart rates in cardiac resynchronization: the art of optimal device programming.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13(2):157-8.
2011: Giuseppe Ambrosio; Marcus D Flather; Michael Böhm; Alain Cohen-Solal; Adriano Murrone; Flavio Mascagni; Giulio Spinucci; Maria Giovanna Conti; Dirk J van Veldhuisen; Luigi Tavazzi; Andrew J S Coats
β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure.
Heart (British Cardiac Society) 2011;97(3):209-14.
2011: Peter Johansson; Maurice Nieuwenhuis; Ivonne Lesman-Leegte; Dirk J van Veldhuisen; Tiny Jaarsma
Depression and the delay between symptom onset and hospitalization in heart failure patients.
European journal of heart failure 2011;13(2):214-9.
2011: Faiez Zannad; John J V McMurray; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Stuart J Pocock; Bertram Pitt
Eplerenone in patients with systolic heart failure and mild symptoms.
The New England journal of medicine 2011;364(1):11-21.
2011: Liza S M Wong; Rudolf A de Boer; Jardi Huzen; Wiek H van Gilst; Dirk J van Veldhuisen; Pim van der Harst
Telomere length of circulating leukocyte subpopulations and buccal cells in patients with ischemic heart failure and their offspring.
PloS one 2011;6(8):e23118.
2011: Giorgio Barbareschi; Robbert Sanderman; Ivonne Lesman Leegte; Dirk J van Veldhuisen; Tiny Jaarsma
Educational level and the quality of life of heart failure patients: a longitudinal study.
Journal of cardiac failure 2011;17(1):47-53.
2011: Suzan Willemsen; Jasper W L Hartog; Yoran M Hummel; Marieke H I van Ruijven; Iwan C C van der Horst; Dirk J van Veldhuisen; Adriaan Voors
Tissue advanced glycation end products are associated with diastolic function and aerobic exercise capacity in diabetic heart failure patients.
European journal of heart failure 2011;13(1):76-82.
2010: Maarten P van den Berg; Karin Y van Spaendonck-Zwarts; Dirk J van Veldhuisen; Jourik A Gietema; Aleida Postma; J Peter van Tintelen
Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
European journal of heart failure 2010;12(12):1297-9.
2010: Peter van der Meer; Erik Lipsic; Dirk J van Veldhuisen
Asialoerythropoietin to protect the failing heart: is it possible to run with the hare and hunt with the hounds?
Journal of the American College of Cardiology 2010;56(23):1959-60.
2010: Christian Ukena; Felix Mahfoud; Michael Kindermann; Ingrid Kindermann; Robert Bals; Adriaan A Voors; Dirk J van Veldhuisen; Michael Böhm
The cardiopulmonary continuum systemic inflammation as 'common soil' of heart and lung disease.
International journal of cardiology 2010;145(2):172-6.
2010: Adriaan A Voors; Anne M S Belonje; Felix Zijlstra; Hans L Hillege; Stefan D Anker; Riemer H J A Slart; René A Tio; Arnoud W J van 't Hof; J Wouter Jukema; Hans Otto J Peels; José P S Henriques; Jurriën M ten Berg; Jeroen Vos; Wiek H van Gilst; Dirk J van Veldhuisen
A single dose of erythropoietin in ST-elevation myocardial infarction.
European heart journal 2010;31(21):2593-600.
2010: Irma Kuipers; Jiang Li; Inge Vreeswijk-Baudoin; Johan Koster; Pim van der Harst; Herman H W Silljé; Folkert Kuipers; Dirk J van Veldhuisen; Wiek H van Gilst; Rudolf A de Boer
Activation of liver X receptors with T0901317 attenuates cardiac hypertrophy in vivo.
European journal of heart failure 2010;12(10):1042-50.
2010: Louis L M van de Ven; Dirk J van Veldhuisen; Michael Goulder; Zsolt Zilahi; Wilfried R Meyer; Ronnie Willenheimer
The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure.
International journal of cardiology 2010;144(1):59-63.
2010: Joost P van Melle; Mariska Bot; Peter de Jonge; Rudolf A de Boer; Dirk J van Veldhuisen; Mary A Whooley
Diabetes, glycemic control, and new-onset heart failure in patients with stable coronary artery disease: data from the heart and soul study.
Diabetes care 2010;33(9):2084-9.
2010: Dirk J van Veldhuisen; Adriaan A Voors; Wiek H van Gilst
The European Journal of Heart Failure in 2010: current impact factor, time-to-first decision, and number of submissions.
European journal of heart failure 2010;12(9):895-7.
2010: Kevin Damman; Adriaan Voors; Hans L Hillege; gerjan navis; Philippe Lechat; Dirk J van Veldhuisen; Henry J Dargie
Congestion in chronic systolic heart failure is related to renal dysfunction and increased mortality.
European journal of heart failure 2010;12(9):974-82.
2010: Willem Drenthen; Eric Boersma; Ali Balci; Philip Moons; Jolien Roos-Hesselink; Barbara J M Mulder; Hubert W Vliegen; Arie P J van Dijk; Adriaan A Voors; Sing-Chien Yap; Dirk J van Veldhuisen; Petronella G Pieper
Predictors of pregnancy complications in women with congenital heart disease.
European heart journal 2010;31(17):2124-32.
2010: Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Jardi Huzen; Wiek H van Gilst; Dirk J van Veldhuisen
Aging, telomeres and heart failure.
Heart failure reviews 2010;15(5):479-86.
2010: Karen Sliwa; Denise Hilfiker-Kleiner; Mark C Petrie; Alexandre Mebazaa; Burkert Pieske; Eckhart Buchmann; Vera Regitz-Zagrosek; Maria Schaufelberger; Luigi Tavazzi; Dirk J van Veldhuisen; Hugh Watkins; Ajay J Shah; Petar M Seferovic; Uri Elkayam; Sabine Pankuweit; Zoltan Papp; Frederic Mouquet; John J V McMurray
Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy.
European journal of heart failure 2010;12(8):767-78.
2010: Kevin Damman; Dirk J van Veldhuisen; gerjan navis; Vishal S Vaidya; Tom D J Smilde; B Daan Westenbrink; Joseph V Bonventre; Adriaan Voors; Hans L Hillege
Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.
Heart (British Cardiac Society) 2010;96(16):1297-302.
2010: Marion Procter; Thomas M Suter; Evandro de Azambuja; Urania Dafni; Veerle van Dooren; Susanne Muehlbauer; Miguel Angel Climent; Ernst Rechberger; Walter Tsang-Wu Liu; Mazakasu Toi; R Charles Coombes; David Dodwell; Olivia Pagani; Jorge Madrid; Marcia Hall; Shin-Cheh Chen; Christian Focan; Michael Muschol; Dirk J van Veldhuisen; Martine J Piccart-Gebhart
Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(21):3422-8.
2010: Willem-Peter T Ruifrok; Erik Lipsic; Rudolf A de Boer; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoiesis stimulation in acute ischemic syndromes.
Heart failure clinics 2010;6(3):313-21.
2010: Rudolf A de Boer; Wolfram Doehner; Iwan C C van der Horst; Stefan D Anker; Daphne Babalis; Michael Roughton; Andrew J Coats; Marcus D Flather; Dirk J van Veldhuisen
Influence of diabetes mellitus and hyperglycemia on prognosis in patients > or =70 years old with heart failure and effects of nebivolol (data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors with heart failure [SENIORS]).
The American journal of cardiology 2010;106(1):78-86.e1.
2010: Sally C Inglis; John J V McMurray; Michael Böhm; Maria Schaufelberger; Dirk J van Veldhuisen; Magnus Lindberg; Peter Dunselman; Ake Hjalmarson; John Kjekshus; Finn Waagstein; Hans Wedel; John Wikstrand
Intermittent claudication as a predictor of outcome in patients with ischaemic systolic heart failure: analysis of the Controlled Rosuvastatin Multinational Trial in Heart Failure trial (CORONA).
European journal of heart failure 2010;12(7):698-705.
2010: B Daan Westenbrink; Adriaan Voors; Rudolf A de Boer; Jan Jacob Schuringa; Theo Klinkenberg; Pim van der Harst; Edo Vellenga; Dirk J van Veldhuisen; Wiek H van Gilst
Bone marrow dysfunction in chronic heart failure patients.
European journal of heart failure 2010;12(7):676-84.
2010: Y M Hummel; I J T Klip; Richard M de Jong; P G Pieper; Dirk J van Veldhuisen; Adriaan Voors
Diastolic function measurements and diagnostic consequences: a comparison of pulsed wave- and color-coded tissue Doppler imaging.
Clinical research in cardiology : official journal of the German Cardiac Society 2010;99(7):453-8.
2010: B Daan Westenbrink; Willem-Peter T Ruifrok; Adriaan A Voors; Ronald G Tilton; Dirk J van Veldhuisen; Regien G Schoemaker; Wiek H van Gilst; Rudolf A de Boer
Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.
Cardiovascular research 2010;87(1):30-9.
2010: Alexander H Maass; Dirk J van Veldhuisen
Device therapy in patients with heart failure and preserved ejection fraction (HFPEF): a new frontier?
European journal of heart failure 2010;12(6):527-9.
2010: Martje H L van der Wal; Dirk J van Veldhuisen; Nic J G M Veeger; Frans H Rutten; Tiny Jaarsma
Compliance with non-pharmacological recommendations and outcome in heart failure patients.
European heart journal 2010;31(12):1486-93.
2010: Faiez Zannad; John J V McMurray; Helmut Drexler; Henry Krum; Dirk J van Veldhuisen; Karl Swedberg; Harry Shi; John Vincent; Bertram Pitt
Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF).
European journal of heart failure 2010;12(6):617-22.
2010: Riemer H J A Slart; René A Tio; P A van der Vleuten; T P Willems; D D Lubbers; Rudi A Dierckx; Dirk J van Veldhuisen
Myocardial perfusion reserve and contractile pattern after beta-blocker therapy in patients with idiopathic dilated cardiomyopathy.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2010;17(3):479-85.
2010: Sheba Ahmed; Adelita Ranchor; Harry J G M Crijns; Dirk J van Veldhuisen; Isabelle C Van Gelder
Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2010;12(6):785-91.
2010: Karin Y van Spaendonck-Zwarts; J Peter van Tintelen; Dirk J van Veldhuisen; Rik van der Werf; Jan D H Jongbloed; Walter J Paulus; Dennis Dooijes; Maarten P van den Berg
Peripartum cardiomyopathy as a part of familial dilated cardiomyopathy.
Circulation 2010;121(20):2169-75.
2010: Maarten P van den Berg; Karin Y van Spaendonck-Zwarts; Dirk J van Veldhuisen
Dilated cardiomyopathy complicates pregnancy outcome: but how?
Journal of the American College of Cardiology 2010;55(20):2291; author reply 2291-2.
2010: William T Abraham; Inder S Anand; Marc Klapholz; Piotr Ponikowski; Debra Scarlata; Scott M Wasserman; Dirk J van Veldhuisen
Treatment of anemia with darbepoetin alfa in heart failure.
Congestive heart failure (Greenwich, Conn.) 2010;16(3):87-95.
2010: W T Ruifrok; B Daan Westenbrink; Rudolf A de Boer; I J den Hamer; Michiel E Erasmus; HE Mungroop; Anne H Epema; Adriaan Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Apoptosis during CABG surgery with the use of cardiopulmonary bypass is prominent in ventricular but not in atrial myocardium.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2010;18(5):236-42.
2010: Mihai Gheorghiade; Ferenc Follath; Piotr Ponikowski; Jeffrey H Barsuk; John E A Blair; John G Cleland; Kenneth Dickstein; Mark H Drazner; Gregg C Fonarow; Tiny Jaarsma; Guillaume Jondeau; Jose Lopez Sendon; Alexander Mebazaa; Marco Metra; Markku Nieminen; Peter S Pang; Petar Seferovic; Lynne W Stevenson; Dirk J van Veldhuisen; Faiez Zannad; Stefan D Anker; Andrew Rhodes; John J V McMurray; Gerasimos Filippatos
Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine.
European journal of heart failure 2010;12(5):423-33.
2010: Isabelle C Van Gelder; Hessel F Groenveld; Harry J G M Crijns; Ype S Tuininga; Jan G P Tijssen; A Marco Alings; Hans L Hillege; Johanna A Bergsma-Kadijk; Jan H Cornel; Otto Kamp; Raymond Tukkie; Hans A Bosker; Dirk J van Veldhuisen; Maarten P van den Berg
Lenient versus strict rate control in patients with atrial fibrillation.
The New England journal of medicine 2010;362(15):1363-73.
2010: Iwan C C van der Horst; Rudolf A de Boer; Hans L Hillege; Frans Boomsma; Adriaan Voors; Dirk J van Veldhuisen
Neurohormonal profile of patients with heart failure and diabetes.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2010;18(4):190-6.
2010: Liza S M Wong; Jardi Huzen; Pim van der Harst; Rudolf A de Boer; Veryan Codd; B Daan Westenbrink; Germaine F J D Benus; Adriaan A Voors; Wiek H van Gilst; Nilesh J Samani; Tiny Jaarsma; Dirk J van Veldhuisen
Anaemia is associated with shorter leucocyte telomere length in patients with chronic heart failure.
European journal of heart failure 2010;12(4):348-53.
2010: Peter J Wijkstra; Dirk J van Veldhuisen
Central sleep apnoea: another important comorbidity in heart failure?
European journal of heart failure 2010;12(4):309-10.
2010: Erik Lipsic; Dirk J van Veldhuisen
Nebivolol in chronic heart failure: current evidence and future perspectives.
Expert opinion on pharmacotherapy 2010;11(6):983-92.
2010: Jasper W L Hartog; Ruud M van de Wal; Casper G Schalkwijk; Toshio Miyata; Wybren Jaarsma; H W Thijs Plokker; LM van Wijk; Andries J Smit; Dirk J van Veldhuisen; Adriaan A Voors
Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction.
European journal of heart failure 2010;12(4):397-403.
2010: Irma Kuipers; Pim van der Harst; Folkert Kuipers; Linda van Genne; Maaike Goris; Jukka Y Lehtonen; Dirk J van Veldhuisen; Wiek H van Gilst; Rudolf A de Boer
Activation of liver X receptor-alpha reduces activation of the renal and cardiac renin-angiotensin-aldosterone system.
Laboratory investigation; a journal of technical methods and pathology 2010;90(4):630-6.
2010: Rudolf A de Boer; Lili Yu; Dirk J van Veldhuisen
Galectin-3 in cardiac remodeling and heart failure.
Current heart failure reports 2010;7(1):1-8.
2010: Martje H L van der Wal; Tiny Jaarsma; Debra Moser; Wiek H van Gilst; Dirk J van Veldhuisen
Qualitative examination of compliance in heart failure patients in The Netherlands.
Heart & lung : the journal of critical care 2010;39(2):121-30.
2010: Veryan Codd; Massimo Mangino; Pim van der Harst; Peter S Braund; Michael Kaiser; Alan J Beveridge; Suzanne Rafelt; Jasbir Moore; Chris Nelson; Nicole Soranzo; Guangju Zhai; Ana M Valdes; Hannah Blackburn; Irene Mateo Leach; Rudolf A de Boer; Alison H Goodall; Willem Ouwehand; Dirk J van Veldhuisen; Wiek H van Gilst; gerjan navis; Paul R Burton; Martin D Tobin; Alistair Hall; John R Thompson; Tim Spector; Abraham Aviv; Masayuki Kimura; Nilesh J Samani
Common variants near TERC are associated with mean telomere length.
Nature genetics 2010;42(3):197-9.
2010: Suzan Willemsen; Jasper W L Hartog; Yoran M Hummel; Jan L Posma; LM van Wijk; Dirk J van Veldhuisen; Adriaan A Voors
Effects of alagebrium, an advanced glycation end-product breaker, in patients with chronic heart failure: study design and baseline characteristics of the BENEFICIAL trial.
European journal of heart failure 2010;12(3):294-300.
2010: Jardi Huzen; Pim van der Harst; Rudolf A de Boer; Ivonne Lesman-Leegte; Adriaan A Voors; Wiek H van Gilst; Nilesh J Samani; Tiny Jaarsma; Dirk J van Veldhuisen
Telomere length and psychological well-being in patients with chronic heart failure.
Age and ageing 2010;39(2):223-7.
2010: Pim van der Harst; Riemer H J A Slart; René A Tio; Peter H J M Dunselman; Antoon T M Willemsen; Ad F M van den Heuvel; Adriaan A Voors; Dirk J van Veldhuisen
Effects of rosuvastatin on coronary flow reserve and metabolic mismatch in patients with heart failure (from the CORONA Study).
The American journal of cardiology 2010;105(4):517-21.
2010: Adriaan A Voors; Ruud M A van de Wal; Jasper W L Hartog; Richard G Vijn; Yoran M Hummel; Thijs W M Plokker; Dirk J van Veldhuisen; Wybren Jaarsma
Effects of eprosartan on diastolic function and neurohormones in patients with hypertension and diastolic dysfunction.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2010;24(1):33-40.
2010: Anne M S Belonje; Adriaan A Voors; peter van der meer; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Endogenous erythropoietin and outcome in heart failure.
Circulation 2010;121(2):245-51.
2010: Marcelle D Smit; Dirk J van Veldhuisen; Isabelle C Van Gelder
Guidelines for atrial fibrillation in heart failure need to be clarified.
Journal of the American College of Cardiology 2010;55(2):167; author reply 168-9.
2010: V M van Deursen; Kevin Damman; Hans L Hillege; A P van Beek; Dirk J van Veldhuisen; Adriaan A Voors
Abnormal liver function in relation to hemodynamic profile in heart failure patients.
Journal of cardiac failure 2010;16(1):84-90.
2010: Katherine Ngo; Dipak Kotecha; J A E Walters; Luis Manzano; Alberto Palazzuoli; Dirk J van Veldhuisen; Marcus Flather
Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients.
Cochrane database of systematic reviews (Online) 2010;(1):CD007613.
2010: Jardi Huzen; Rudolf A de Boer; Dirk J van Veldhuisen; Wiek H van Gilst; Pim van der Harst
The emerging role of telomere biology in cardiovascular disease.
Frontiers in bioscience : a journal and virtual library 2010;15():35-45.
2010: PK Lorgelly; Andrew H Briggs; Hans Wedel; Peter Dunselman; Ake Hjalmarson; John Kjekshus; Finn Waagstein; John Wikstrand; András Jánosi; Dirk J van Veldhuisen; Vivencio Barrios; Cândida Fonseca; John J V McMurray
An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial.
European journal of heart failure 2010;12(1):66-74.
2010: Pim van der Harst; Rudolf A de Boer; Nilesh J Samani; Liza S M Wong; Jardi Huzen; Veryan Codd; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Telomere length and outcome in heart failure.
Annals of medicine 2010;42(1):36-44.
2010: Gerard C M Linssen; Stephan J L Bakker; Adriaan Voors; Ron T Gansevoort; Hans L Hillege; Paul E de Jong; Dirk J van Veldhuisen; Rijk O B Gans; Dick De Zeeuw
N-terminal pro-B-type natriuretic peptide is an independent predictor of cardiovascular morbidity and mortality in the general population.
European heart journal 2010;31(1):120-7.
2009: René A Tio; R H J A Slart; R A de Boer; Pieter A van der Vleuten; Richard M de Jong; LM van Wijk; Tineke P Willems; D D Lubbers; Adriaan Voors; Dirk J van Veldhuisen
Reduced regional myocardial perfusion reserve is associated with impaired contractile performance in idiopathic dilated cardiomyopathy.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2009;17(12):470-4.
2009: Ivonne Lesman-Leegte; Dirk J van Veldhuisen; Hans L Hillege; Debra Moser; Robbert Sanderman; Tiny Jaarsma
Depressive symptoms and outcomes in patients with heart failure: data from the COACH study.
European journal of heart failure 2009;11(12):1202-7.
2009: Pim van der Harst; Rudolf A de Boer; Dirk J van Veldhuisen
The Nobel Prize for medicine for telomere biology and relevance to heart failure research.
European journal of heart failure 2009;11(12):1113-5.
2009: Dirk J van Veldhuisen; Alexander H Maass; Silvia G Priori; Pelle Stolt; Isabelle C Van Gelder; Kenneth Dickstein; Karl Swedberg
Implementation of device therapy (cardiac resynchronization therapy and implantable cardioverter defibrillator) for patients with heart failure in Europe: changes from 2004 to 2008.
European journal of heart failure 2009;11(12):1143-51.
2009: John G F Cleland; John J V McMurray; John Kjekshus; Jan H Cornel; Peter Dunselman; Cândida Fonseca; Ake Hjalmarson; Jerzy Korewicki; Magnus Lindberg; Naresh Ranjith; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in Heart Failure).
Journal of the American College of Cardiology 2009;54(20):1850-9.
2009: Hessel F Groenveld; Harry J G M Crijns; Michiel Rienstra; Maarten P van den Berg; Dirk J van Veldhuisen; Isabelle C Van Gelder
Does intensity of rate control influence outcome in persistent atrial fibrillation? Data of the RACE study.
American heart journal 2009;158(5):785-91.
2009: peter van der meer; Dirk J van Veldhuisen
Anaemia and renal dysfunction in chronic heart failure.
Heart (British Cardiac Society) 2009;95(21):1808-12.
2009: Marc Klapholz; William T Abraham; Jalal K Ghali; Piotr Ponikowski; Stefan D Anker; Beat Knusel; Yan Sun; Scott M Wasserman; Dirk J van Veldhuisen
The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure.
European journal of heart failure 2009;11(11):1071-7.
2009: Kenneth Dickstein; Nigussie Bogale; Silvia Priori; Angelo Auricchio; John G F Cleland; Anselm Gitt; Tobias Limbourg; Cecilia Linde; Dirk J van Veldhuisen; Josep Brugada
The European cardiac resynchronization therapy survey.
European heart journal 2009;30(20):2450-60.
2009: Liza S M Wong; Pim van der Harst; Rudolf A de Boer; Veryan Codd; Jardi Huzen; Nilesh J Samani; Hans L Hillege; Adriaan A Voors; Wiek H van Gilst; Tiny Jaarsma; Dirk J van Veldhuisen
Renal dysfunction is associated with shorter telomere length in heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(10):629-34.
2009: S Buck; A H Maass; Dirk J van Veldhuisen; Isabelle C Van Gelder
Cardiac resynchronisation therapy and the role of optimal device utilisation.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2009;17(9):354-7.
2009: Kevin Damman; Tiny Jaarsma; Adriaan A Voors; gerjan navis; Hans L Hillege; Dirk J van Veldhuisen
Both in- and out-hospital worsening of renal function predict outcome in patients with heart failure: results from the Coordinating Study Evaluating Outcome of Advising and Counseling in Heart Failure (COACH).
European journal of heart failure 2009;11(9):847-54.
2009: Richard M de Jong; René A Tio; Pim van der Harst; Adriaan A Voors; Paul M Koning; Clark J A M Zeebregts; Dirk J van Veldhuisen; Rudi A J O Dierckx; Riemer H J A Slart
Ischemic patterns assessed by positron emission tomography predict adverse outcome in patients with idiopathic dilated cardiomyopathy.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2009;16(5):769-74.
2009: Alain Cohen-Solal; Dipak Kotecha; Dirk J van Veldhuisen; Daphne Babalis; Michael Böhm; Andrew J Coats; Michael Roughton; Philip Poole-Wilson; Luigi Tavazzi; Marcus Flather
Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial.
European journal of heart failure 2009;11(9):872-80.
2009: Rudolf A de Boer; Adriaan A Voors; Pieter Muntendam; Wiek H van Gilst; Dirk J van Veldhuisen
Galectin-3: a novel mediator of heart failure development and progression.
European journal of heart failure 2009;11(9):811-7.
2009: Kevin Damman; Hans L Hillege; Dirk J van Veldhuisen
Albuminuria in heart failure: a CHARMing new risk factor?
Lancet 2009;374(9689):506-8.
2009: John J V McMurray; Inder S Anand; Rafael Diaz; Aldo P Maggioni; Christopher O'Connor; Marc A Pfeffer; Krishna R Polu; Scott D Solomon; Yan Sun; Karl Swedberg; Michal Tendera; Dirk J van Veldhuisen; Scott M Wasserman; James B Young
Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial.
European journal of heart failure 2009;11(8):795-801.
2009: Rudolf A de Boer; Pim van der Harst; Dirk J van Veldhuisen; Maarten P van den Berg
Pharmacogenetics in heart failure: promises and challenges.
Expert opinion on pharmacotherapy 2009;10(11):1713-25.
2009: P van der Meer; H F Groenveld; James L Januzzi; Dirk J van Veldhuisen
Erythropoietin treatment in patients with chronic heart failure: a meta-analysis.
Heart (British Cardiac Society) 2009;95(16):1309-14.
2009: Dirk J van Veldhuisen; Rudolf A de Boer
Low-dose digoxin in heart failure.
International journal of cardiology 2009;136(1):90-1; author reply 91-2.
2009: Gerard C M Linssen; Kevin Damman; Hans L Hillege; gerjan navis; Dirk J van Veldhuisen; Adriaan A Voors
Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure.
Circulation 2009;120(1):35-41.
2009: Alexander H Maass; Sandra Buck; Wybe Nieuwland; Johan Brügemann; Dirk J van Veldhuisen; Isabelle C Van Gelder
Importance of heart rate during exercise for response to cardiac resynchronization therapy.
Journal of cardiovascular electrophysiology 2009;20(7):773-80.
2009: Dirk J van Veldhuisen; Alain Cohen-Solal; Michael Böhm; Stefan D Anker; Daphne Babalis; Michael Roughton; Andrew J S Coats; Philip A Poole-Wilson; Marcus D Flather
Beta-blockade with nebivolol in elderly heart failure patients with impaired and preserved left ventricular ejection fraction: Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure).
Journal of the American College of Cardiology 2009;53(23):2150-8.
2009: Marcelle D Smit; Isabelle C Van Gelder; Michael Böhm; Hans-Ruprecht Neuberger; Dirk J van Veldhuisen
Should aldosterone blockade be used beyond current indications in heart failure?
Current heart failure reports 2009;6(2):117-25.
2009: Jacqueline Savva; Azhar Maqbool; Hazel L White; Stacey L Galloway; Nadira Y Yuldasheva; Stephen G Ball; Robert M West; Rudolf A de Boer; Dirk J van Veldhuisen; Anthony J Balmforth
Polymorphisms of adrenoceptors are not associated with an increased risk of adverse event in heart failure: a MERIT-HF substudy.
Journal of cardiac failure 2009;15(5):435-41.
2009: M M Winter; Berto J Bouma; Maarten Groenink; T C Konings; J G P Tijssen; Dirk J van Veldhuisen; Barbara J M Mulder
Latest insights in therapeutic options for systemic right ventricular failure: a comparison with left ventricular failure.
Heart (British Cardiac Society) 2009;95(12):960-3.
2009: Jalal K Ghali; John Wikstrand; Dirk J van Veldhuisen; Björn Fagerberg; Sidney Goldstein; Ake Hjalmarson; Peter Johansson; John Kjekshus; Lis Ohlsson; Ola Samuelsson; Finn Waagstein; Hans Wedel
The influence of renal function on clinical outcome and response to beta-blockade in systolic heart failure: insights from Metoprolol CR/XL Randomized Intervention Trial in Chronic HF (MERIT-HF).
Journal of cardiac failure 2009;15(4):310-8.
2009: Adriaan A Voors; Stephan von Haehling; Stefan D Anker; Hans L Hillege; Joachim Struck; Oliver Hartmann; Andreas Bergmann; Iain Squire; Dirk J van Veldhuisen; Kenneth Dickstein
C-terminal provasopressin (copeptin) is a strong prognostic marker in patients with heart failure after an acute myocardial infarction: results from the OPTIMAAL study.
European heart journal 2009;30(10):1187-94.
2009: Renske Altena; Patrick J Perik; Dirk J van Veldhuisen; Elisabeth Ge de Vries; Jourik A Gietema
Cardiovascular toxicity caused by cancer treatment: strategies for early detection.
The lancet oncology 2009;10(4):391-9.
2009: Tom D J Smilde; Dirk J van Veldhuisen; Maarten P van den Berg
Prognostic value of heart rate variability and ventricular arrhythmias during 13-year follow-up in patients with mild to moderate heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(4):233-9.
2009: Kevin Damman; Vincent M van Deursen; gerjan navis; Adriaan A Voors; Dirk J van Veldhuisen; Hans L Hillege
Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.
Journal of the American College of Cardiology 2009;53(7):582-8.
2009: Kevin Damman; Dirk J van Veldhuisen; Hans L Hillege
Cardiac resynchronization therapy improves renal function: importance of forward and backward failure.
Journal of cardiac failure 2009;15(1):78-9; author reply 79-80.
2009: Ivonne Lesman-Leegte; Tiny Jaarsma; James C Coyne; Hans L Hillege; Dirk J van Veldhuisen; Robbert Sanderman
Quality of life and depressive symptoms in the elderly: a comparison between patients with heart failure and age- and gender-matched community controls.
Journal of cardiac failure 2009;15(1):17-23.
2009: René A Tio; Ali Dabeshlim; Hans-Marc J Siebelink; Johan de Sutter; Hans L Hillege; Clark J Zeebregts; Rudi A J O Dierckx; Dirk J van Veldhuisen; Felix Zijlstra; Riemer H J A Slart
Comparison between the prognostic value of left ventricular function and myocardial perfusion reserve in patients with ischemic heart disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2009;50(2):214-9.
2009: Liza S M Wong; Hisko Oeseburg; Rudolf A de Boer; Wiek H van Gilst; Dirk J van Veldhuisen; Pim van der Harst
Telomere biology in cardiovascular disease: the TERC-/- mouse as a model for heart failure and ageing.
Cardiovascular research 2009;81(2):244-52.
2009: Tom D J Smilde; Kevin Damman; Pim van der Harst; gerjan navis; B Daan Westenbrink; Adriaan A Voors; Frans Boomsma; Dirk J van Veldhuisen; Hans L Hillege
Differential associations between renal function and "modifiable" risk factors in patients with chronic heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2009;98(2):121-9.
2009: Colin J Petrie; Adriaan A Voors; Dirk J van Veldhuisen
Low pulse pressure is an independent predictor of mortality and morbidity in non ischaemic, but not in ischaemic advanced heart failure patients.
International journal of cardiology 2009;131(3):336-44.
2009: Johan Brügemann; Wim van Der Bij; Erik A M Verschuuren; Aafke A Klungel; Iwan C C van der Horst; Michiel E Erasmus; Huib A M Kerstjens; Dirk J van Veldhuisen; Felix Zijlstra
[Experiences of combined heart-lung transplantations in the University Medical Center Groningen].
Nederlands tijdschrift voor geneeskunde 2009;153():B98.
2008: Karl Swedberg; John G F Cleland; Martin R Cowie; Markku Nieminen; silvia priori; Luigi Tavazzi; Dirk J van Veldhuisen; Luis Alonso-Pulpon; John Camm; Kenneth Dickstein; Helmut Drexler; Gerasimos Filippatos; Cecilia Linde; José Lopez-Sendon; Massimo Santini; Faiez Zannad
Successful treatment of heart failure with devices requires collaboration.
European journal of heart failure 2008;10(12):1229-35.
2008: Jardi Huzen; Dirk J van Veldhuisen; Pim van der Harst
Letter by Huzen et al regarding article, "Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study".
Circulation 2008;118(19):e688; author reply e689.
2008: Michael Kindermann; Jan-Christian Reil; Burkert Pieske; Dirk J van Veldhuisen; Michael Böhm
Heart failure with normal left ventricular ejection fraction: what is the evidence?
Trends in cardiovascular medicine 2008;18(8):280-92.
2008: Sandra Buck; Alexander H Maass; Wybe Nieuwland; Rutger L Anthonio; Dirk J van Veldhuisen; Isabelle C Van Gelder
Impact of interventricular lead distance and the decrease in septal-to-lateral delay on response to cardiac resynchronization therapy.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(11):1313-9.
2008: Sheba Ahmed; Michiel Rienstra; Harry J G M Crijns; Thera P Links; Ans C P Wiesfeld; Hans L Hillege; Hans A Bosker; Dirk J A Lok; Dirk J van Veldhuisen; Isabelle C Van Gelder
Continuous vs episodic prophylactic treatment with amiodarone for the prevention of atrial fibrillation: a randomized trial.
JAMA : the journal of the American Medical Association 2008;300(15):1784-92.
2008: Kevin Damman; Dirk J van Veldhuisen; gerjan navis; Adriaan A Voors; Hans L Hillege
Urinary neutrophil gelatinase associated lipocalin (NGAL), a marker of tubular damage, is increased in patients with chronic heart failure.
European journal of heart failure 2008;10(10):997-1000.
2008: Daniela Dobre; Dirk J van Veldhuisen; Michael A Goulder; Henry Krum; Ronnie Willenheimer
Clinical effects of initial 6 months monotherapy with bisoprolol versus enalapril in the treatment of patients with mild to moderate chronic heart failure. Data from the CIBIS III Trial.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22(5):399-405.
2008: Tiny Jaarsma; M H L van der Wal; Ivonne Lesman-Leegte; Marie Louise Luttik; Jochem Hogenhuis; N J Veeger; Robbert Sanderman; Arno Hoes; Wiek H van Gilst; D J A Lok; P H J M Dunselman; J G P Tijssen; Hans L Hillege; Dirk J van Veldhuisen
[Value of basic and intensive management of patients with heart failure; results of a randomised controlled clinical trial].
Nederlands tijdschrift voor geneeskunde 2008;152(37):2016-21.
2008: Hessel F Groenveld; James L Januzzi; Kevin Damman; Jan van Wijngaarden; Hans L Hillege; Dirk J van Veldhuisen; peter van der meer
Anemia and mortality in heart failure patients a systematic review and meta-analysis.
Journal of the American College of Cardiology 2008;52(10):818-27.
2008: Jasper W L Hartog; Yoran M Hummel; Adriaan A Voors; Casper G Schalkwijk; Toshio Miyata; Roel M Huisman; Andries J Smit; Dirk J van Veldhuisen
Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients.
Journal of cardiac failure 2008;14(7):596-602.
2008: Frieder Braunschweig; Ian Ford; Viviane Conraads; Martin R Cowie; Guillaume Jondeau; Josef Kautzner; Maurizio Lunati; Roberto Munoz Aguilera; Cheuk Man Yu; Monique Marijianowski; Martin Borggrefe; Dirk J van Veldhuisen
Can monitoring of intrathoracic impedance reduce morbidity and mortality in patients with chronic heart failure? Rationale and design of the Diagnostic Outcome Trial in Heart Failure (DOT-HF).
European journal of heart failure 2008;10(9):907-16.
2008: Kevin Damman; Rudolf A de Boer; Dirk J van Veldhuisen
Heart failure, aging and beta-blockers: the need for more data on tolerability and efficacy.
Clinical research in cardiology : official journal of the German Cardiac Society 2008;97(9):575-7.
2008: Anca Radauceanu; Camille Ducki; jean-marc virion; Patrick Rossignol; Ziad Mallat; John McMurray; Dirk J van Veldhuisen; Luigi Tavazzi; Douglas L Mann; Josette Capiaumont-Vin; Minjiang Li; Didier Hanriot; Faiez Zannad
Extracellular matrix turnover and inflammatory markers independently predict functional status and outcome in chronic heart failure.
Journal of cardiac failure 2008;14(6):467-74.
2008: Rudolf A de Boer; Dirk J van Veldhuisen
ACE-inhibitors, beta-blockers or the combination in heart failure: is it just an A-B-C ? : editorial to: effects of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure by Rosenberg et al.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22(4):261-3.
2008: B Daan Westenbrink; Hisko Oeseburg; Lennaert Kleijn; Pim van der Harst; Anne M S Belonje; Adriaan A Voors; Regien G Schoemaker; Rudolf A de Boer; Dirk J van Veldhuisen; Wiek H van Gilst
Erythropoietin stimulates normal endothelial progenitor cell-mediated endothelial turnover, but attributes to neovascularization only in the presence of local ischemia.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2008;22(4):265-74.
2008: Pim van der Harst; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of fosinopril treatment on serum C-reactive protein levels in patients with microalbuminuria.
The American journal of cardiology 2008;102(2):223-5.
2008: Pim van der Harst; Liza S M Wong; Rudolf A de Boer; Scott Brouilette; Gerrit van der Steege; Adriaan A Voors; Alistair Hall; Nilesh J Samani; John Wikstrand; Wiek H van Gilst; Dirk J van Veldhuisen
Possible association between telomere length and renal dysfunction in patients with chronic heart failure.
The American journal of cardiology 2008;102(2):207-10.
2008: peter van der meer; Dirk J Lok; James L Januzzi; Pieta W Bruggink-Andre de la Porte; Erik Lipsic; Jan van Wijngaarden; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Adequacy of endogenous erythropoietin levels and mortality in anaemic heart failure patients.
European heart journal 2008;29(12):1510-5.
2008: Irma Kuipers; Pim van der Harst; gerjan navis; Linda van Genne; Fulvio Morello; Wiek H van Gilst; Dirk J van Veldhuisen; Rudolf A de Boer
Nuclear hormone receptors as regulators of the renin-angiotensin-aldosterone system.
Hypertension 2008;51(6):1442-8.
2008: Ivonne Lesman-Leegte; Tiny Jaarsma; Robbert Sanderman; Hans L Hillege; Dirk J van Veldhuisen
Determinants of depressive symptoms in hospitalised men and women with heart failure.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2008;7(2):121-6.
2008: J Huzen; Dirk J van Veldhuisen; Wiek H van Gilst; Pim van der Harst
[Telomeres and biological ageing in cardiovascular disease].
Nederlands tijdschrift voor geneeskunde 2008;152(22):1265-70.
2008: Willem-Peter T Ruifrok; Rudolf A de Boer; B Daan Westenbrink; Dirk J van Veldhuisen; Wiek H van Gilst
Erythropoietin in cardiac disease: new features of an old drug.
European journal of pharmacology 2008;585(2-3):270-7.
2008: Anne M Belonje; Adriaan A Voors; Wiek H van Gilst; Stefan D Anker; Riemer H J A Slart; Rene A Tio; Felix Zijlstra; Dirk J van Veldhuisen
Effects of erythropoietin after an acute myocardial infarction: rationale and study design of a prospective, randomized, clinical trial (HEBE III).
American heart journal 2008;155(5):817-22.
2008: Pim van der Harst; Dirk J van Veldhuisen; Nilesh J Samani
Expanding the concept of telomere dysfunction in cardiovascular disease.
Arteriosclerosis, thrombosis, and vascular biology 2008;28(5):807-8.
2008: Sandra Buck; Michiel Rienstra; Alexander H Maass; Wybe Nieuwland; Dirk J van Veldhuisen; Isabelle C Van Gelder
Cardiac resynchronization therapy in patients with heart failure and atrial fibrillation: importance of new-onset atrial fibrillation and total atrial conduction time.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2008;10(5):558-65.
2008: Tiny Jaarsma; Ivonne Lesman; Dirk J van Veldhuisen
Psychology and cardiology: do not forget the heart failure patient.
European heart journal 2008;29(9):1208; author reply 1208-9.
2008: Daniela Dobre; Mike J L de Jongste; Flora M Haaijer-Ruskamp; Robbert Sanderman; Dirk J van Veldhuisen; Adelita Ranchor
The enigma of quality of life in patients with heart failure.
International journal of cardiology 2008;125(3):407-9.
2008: peter van der meer; Dirk J van Veldhuisen
[New applications of erythropoietin in cardiovascular disease: from haematopoiesis to cardiac protection].
Nederlands tijdschrift voor geneeskunde 2008;152(16):923-7.
2008: Andries J Smit; Jasper W L Hartog; Adriaan A Voors; Dirk J van Veldhuisen
Advanced glycation endproducts in chronic heart failure.
Annals of the New York Academy of Sciences 2008;1126():225-30.
2008: Tiny Jaarsma; Dirk J van Veldhuisen
When, how and where should we "coach" patients with heart failure: the COACH results in perspective.
European journal of heart failure 2008;10(4):331-3.
2008: B Daan Westenbrink; Rudolf A de Boer; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Anemia in chronic heart failure: etiology and treatment options.
Current opinion in cardiology 2008;23(2):141-7.
2008: Pim van der Harst; Michael Böhm; Wiek H van Gilst; Dirk J van Veldhuisen
The case for statin therapy in chronic heart failure.
Clinical research in cardiology : official journal of the German Cardiac Society 2008;97(3):139-46.
2008: Marie Louise Luttik; Tiny Jaarsma; Jan G P Tijssen; Dirk J van Veldhuisen; Robbert Sanderman
The objective burden in partners of heart failure patients; development and initial validation of the Dutch Objective Burden Inventory.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2008;7(1):3-9.
2008: Tiny Jaarsma; Martje H L van der Wal; Ivonne Lesman-Leegte; Marie Louise Luttik; Jochem Hogenhuis; Nic J G M Veeger; Robbert Sanderman; Arno Hoes; Wiek H van Gilst; Dirk J A Lok; Peter H J M Dunselman; Jan G P Tijssen; Hans L Hillege; Dirk J van Veldhuisen
Effect of moderate or intensive disease management program on outcome in patients with heart failure: Coordinating Study Evaluating Outcomes of Advising and Counseling in Heart Failure (COACH).
Archives of internal medicine 2008;168(3):316-24.
2008: peter van der meer; Dirk J van Veldhuisen; James L Januzzi
Erythropoietin in cardiovascular diseases: exploring new avenues.
Clinical science (London, England : 1979) 2008;114(4):289-91.
2008: Daniel D Lubbers; Tineke P Willems; Pieter A van der Vleuten; Jelle Overbosch; Marco J W Götte; Dirk J van Veldhuisen; Matthijs Oudkerk
Assessment of global left ventricular functional parameters: analysis of every second short-axis Magnetic Resonance Imaging slices is as accurate as analysis of consecutive slices.
The international journal of cardiovascular imaging 2008;24(2):185-91.
2008: peter van der meer; Erik Lipsic; Wiek H van Gilst; Dirk J van Veldhuisen
Anemia and erythropoietin in heart failure.
Heart failure monitor 2008;6(1):28-33.
2008: Folkert Asselbergs; M P van den Berg; Stephan J.L. Bakker; J E Signorovitch; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
N-terminal pro B-type natriuretic peptide levels predict newly detected atrial fibrillation in a population-based cohort.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2008;16(3):73-8.
2008: Rudolf A de Boer; Dirk J van Veldhuisen
Letter by de Boer and van Veldhuisen regarding article, "Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)".
Circulation 2008;117(1):e7; author reply e8.
2008: Erik Lipsic; B Daan Westenbrink; peter van der meer; Pim van der Harst; Adriaan A Voors; Dirk J van Veldhuisen; Regien G Schoemaker; Wiek H van Gilst
Low-dose erythropoietin improves cardiac function in experimental heart failure without increasing haematocrit.
European journal of heart failure 2008;10(1):22-9.
2008: Willem Drenthen; Petronella G Pieper; Karin van der Tuuk; Jolien Roos-Hesselink; Elke S Hoendermis; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Sing-Chien Yap; Hubert W Vliegen; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Fertility, pregnancy and delivery in women after biventricular repair for double outlet right ventricle.
Cardiology 2008;109(2):105-9.
2007: Patrick J Perik; Maarten Alexander de Korte; Dirk J van Veldhuisen; Jourik A Gietema; Dirk T Sleijfer; Elisabeth G E de Vries
Cardiotoxicity associated with the use of trastuzumab in breast cancer patients.
Expert review of anticancer therapy 2007;7(12):1763-71.
2007: Jasper W L Hartog; Adriaan A Voors; Stephan J L Bakker; Andries J Smit; Dirk J van Veldhuisen
Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications.
European journal of heart failure 2007;9(12):1146-55.
2007: Jasper W L Hartog; Adriaan A Voors; Casper G Schalkwijk; Jean Scheijen; Tom D J Smilde; Kevin Damman; Stephan J L Bakker; Andries J Smit; Dirk J van Veldhuisen
Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
European heart journal 2007;28(23):2879-85.
2007: John Kjekshus; Eduard Apetrei; Vivencio Barrios; Michael Böhm; John G F Cleland; Jan H Cornel; Peter H J M Dunselman; Cândida Fonseca; Assen R Goudev; Peer Grande; Lars Gullestad; Ake Hjalmarson; Jaromir Hradec; András Jánosi; Gabriel Kamenský; Michel Komajda; Jerzy Korewicki; Timo Kuusi; François Mach; Vyacheslav Mareev; john mcmurray; Naresh Ranjith; Maria Schaufelberger; Johan Vanhaecke; Dirk J van Veldhuisen; Finn Waagstein; Hans Wedel; John Wikstrand
Rosuvastatin in older patients with systolic heart failure.
The New England journal of medicine 2007;357(22):2248-61.
2007: Pim van der Harst; Folkert Asselbergs; Hans L Hillege; Stephan J L Bakker; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of withdrawal of pravastatin therapy on C-reactive protein and low-density lipoprotein cholesterol.
The American journal of cardiology 2007;100(10):1548-51.
2007: john mcmurray; John R Teerlink; Gad Cotter; Robert Bourge; John G F Cleland; Guillaume Jondeau; Henry Krum; Marco Metra; Christopher M O'Connor; John D Parker; Guillermo Torre Amione; Dirk J van Veldhuisen; Jim Lewsey; Aline Frey; Maurizio Rainisio; Isaac Kobrin
Effects of tezosentan on symptoms and clinical outcomes in patients with acute heart failure: the VERITAS randomized controlled trials.
JAMA : the journal of the American Medical Association 2007;298(17):2009-19.
2007: Hisko Oeseburg; B Daan Westenbrink; Rudolf A de Boer; Wiek H van Gilst; Dirk J van Veldhuisen; Pim van der Harst
Can critically short telomeres cause functional exhaustion of progenitor cells in postinfarction heart failure?
Journal of the American College of Cardiology 2007;50(19):1911-2; author reply 1912-3.
2007: Johan Brügemann; A T G de Jonge-Weber; Michiel Rienstra; S A J van den Broek; Felix Zijlstra; Dirk J van Veldhuisen
[Dobutamine therapy at home under the guidance of a nurse practitioner, either as a bridge to cardiac transplantation or as destination therapy in severe heart failure].
Nederlands tijdschrift voor geneeskunde 2007;151(44):2460-5.
2007: Hans-Ruprecht Neuberger; Christian Mewis; Dirk J van Veldhuisen; Ulrich Schotten; Isabelle C Van Gelder; Maurits A Allessie; Michael Böhm
Management of atrial fibrillation in patients with heart failure.
European heart journal 2007;28(21):2568-77.
2007: Ruud M A van de Wal; Pim van der Harst; Lodewijk J Wagenaar; Sven Wassmann; Wim J Morshuis; G Nickenig; Hendrik Buikema; H W M Plokker; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
Journal of cardiovascular pharmacology 2007;50(4):372-9.
2007: Adriaan A Voors; Colin J Petrie; Dirk J van Veldhuisen
Prognostic value of pulse pressure in heart failure.
Journal of cardiac failure 2007;13(8):694.
2007: Kevin Damman; gerjan navis; Adriaan A Voors; Folkert Asselbergs; Tom D J Smilde; John G F Cleland; Dirk J van Veldhuisen; Hans L Hillege
Worsening renal function and prognosis in heart failure: systematic review and meta-analysis.
Journal of cardiac failure 2007;13(8):599-608.
2007: Tom D J Smilde; Mike W Zuurman; Hans L Hillege; Dirk J van Veldhuisen; Wiek H van Gilst; Gerrit van der Steege; Adriaan A Voors; Jan A Kors; Paul E de Jong; gerjan navis
Renal function dependent association of AGTR1 polymorphism (A1166C) and electrocardiographic left-ventricular hypertrophy.
American journal of hypertension 2007;20(10):1097-103.
2007: Daniela Dobre; Dirk J van Veldhuisen; Mike J L DeJongste; Eric van Sonderen; Olaf Klungel; Robbert Sanderman; Adelita Ranchor; Flora M Haaijer-Ruskamp
The contribution of observational studies to the knowledge of drug effectiveness in heart failure.
British journal of clinical pharmacology 2007;64(4):406-14.
2007: Anne M S Belonje; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoietin in chronic heart failure.
Congestive heart failure (Greenwich, Conn.) 2007;13(5):289-92.
2007: B Daan Westenbrink; Adriaan A Voors; Willem-Peter T Ruifrok; Wiek H van Gilst; Dirk J van Veldhuisen
Therapeutic potential of erythropoietin in cardiovascular disease: erythropoiesis and beyond.
Current heart failure reports 2007;4(3):127-33.
2007: Maarten Alexander de Korte; E G E de Vries; Marjolijn N Lub-de Hooge; Pieter L Jager; Jourik A Gietema; Winette T A van der Graaf; Wim J Sluiter; Dirk J van Veldhuisen; T M Suter; Dirk T Sleijfer; Patrick J Perik
111Indium-trastuzumab visualises myocardial human epidermal growth factor receptor 2 expression shortly after anthracycline treatment but not during heart failure: a clue to uncover the mechanisms of trastuzumab-related cardiotoxicity.
European journal of cancer (Oxford, England : 1990) 2007;43(14):2046-51.
2007: Dirk J van Veldhuisen; Kenneth Dickstein; Alain Cohen-Solal; Dirk J A Lok; Scott M Wasserman; Nigel Baker; Dylan Rosser; John G F Cleland; Piotr Ponikowski
Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia.
European heart journal 2007;28(18):2208-16.
2007: Thomas M Suter; Marion Procter; Dirk J van Veldhuisen; Michael Muscholl; Jonas Bergh; Chiara Carlomagno; Timothy Perren; Rodolfo Passalacqua; Claudia Bighin; Jan G M Klijn; Fail T Ageev; Erika Hitre; Juergen Groetz; Hiroji Iwata; Malgorzata Knap; Michael Gnant; Susanne Muehlbauer; Alison Spence; Richard D Gelber; Martine J Piccart-Gebhart
Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(25):3859-65.
2007: Kevin Damman; gerjan navis; Tom D J Smilde; Adriaan A Voors; Wim van der Bij; Dirk J van Veldhuisen; Hans L Hillege
Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction.
European journal of heart failure 2007;9(9):872-8.
2007: B Daan Westenbrink; Erik Lipsic; peter van der meer; Pim van der Harst; Hisko Oeseburg; Gideon J Du Marchie Sarvaas; Johan Koster; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.
European heart journal 2007;28(16):2018-27.
2007: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Arno Hoes; Hans L Hillege; Johannes A Kragten; Dirk J van Veldhuisen
Anaemia and renal dysfunction are independently associated with BNP and NT-proBNP levels in patients with heart failure.
European journal of heart failure 2007;9(8):787-94.
2007: Rudolf A de Boer; Adriaan A Voors; Dirk J van Veldhuisen
Nebivolol: third-generation beta-blockade.
Expert opinion on pharmacotherapy 2007;8(10):1539-50.
2007: Martje H L van der Wal; Tiny Jaarsma; Debra Moser; Wiek H van Gilst; Dirk J van Veldhuisen
Unraveling the mechanisms for heart failure patients' beliefs about compliance.
Heart & lung : the journal of critical care 2007;36(4):253-61.
2007: Wouter B A Eijkelkamp; Pieter A de Graeff; Dirk J van Veldhuisen; Richard P E van Dokkum; Ron T Gansevoort; Paul E de Jong; Dick De Zeeuw; Hans L Hillege
Effect of first myocardial ischemic event on renal function.
The American journal of cardiology 2007;100(1):7-12.
2007: Daniela Dobre; Dirk J van Veldhuisen; Giacomo Mordenti; Marius Vintila; Flora M Haaijer-Ruskamp; Andrew J S Coats; Philip A Poole-Wilson; Marcus Flather
Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial.
American heart journal 2007;154(1):109-15.
2007: Pieta W F Bruggink-André de la Porte; Dirk J A Lok; Dirk J van Veldhuisen; Jan van Wijngaarden; Jan H Cornel; Nicolaas P A Zuithoff; Erik Badings; Arno Hoes
Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study.
Heart (British Cardiac Society) 2007;93(7):819-25.
2007: J Peter van Tintelen; Rene A Tio; Wilhelmina S Kerstjens-Frederikse; Jop H van Berlo; Ludolf G Boven; Albert J H Suurmeijer; Stefan J White; Johan T den Dunnen; Gerard te Meerman; Yvonne J Vos; Annemarie H Van Der Hout; Jan Osinga; Maarten P van den Berg; Dirk J van Veldhuisen; Charles H C M Buys; Robert M W Hofstra; Yigal M Pinto
Severe myocardial fibrosis caused by a deletion of the 5' end of the lamin A/C gene.
Journal of the American College of Cardiology 2007;49(25):2430-9.
2007: Johan Brügemann; Bas J J Poels; Mieke H Oosterwijk; Cees P van der Schans; Klaas Postema; Dirk J van Veldhuisen
A randomised controlled trial of cardiac rehabilitation after revascularisation.
International journal of cardiology 2007;119(1):59-64.
2007: Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; Willem A van Lottum; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Sing C Yap; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Outcome of pregnancy in women with congenital heart disease: a literature review.
Journal of the American College of Cardiology 2007;49(24):2303-11.
2007: B Daan Westenbrink; Adriaan A Voors; Dirk J van Veldhuisen
Is anemia in chronic heart failure caused by iron deficiency?
Journal of the American College of Cardiology 2007;49(23):2301-2; author reply 2302.
2007: Marie Louise Luttik; Tiny Jaarsma; Nic J G M Veeger; Jan G P Tijssen; Robbert Sanderman; Dirk J van Veldhuisen
Caregiver burden in partners of Heart Failure patients; limited influence of disease severity.
European journal of heart failure 2007;9(6-7):695-701.
2007: Pim van der Harst; Gerrit van der Steege; Rudolf A de Boer; Adriaan A Voors; Alistair Hall; Marcel J Mulder; Wiek H van Gilst; Dirk J van Veldhuisen
Telomere length of circulating leukocytes is decreased in patients with chronic heart failure.
Journal of the American College of Cardiology 2007;49(13):1459-64.
2007: Martin E W Hemels; Ans C P Wiesfeld; Dirk J van Veldhuisen; Maarten P van den Berg; Isabelle C Van Gelder
Outcome of pharmacological rhythm control for new-onset persistent atrial fibrillation in patients with systolic heart failure: a comparison with patients with normal left ventricular function.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2007;9(4):239-45.
2007: Iwan C C van der Horst; Adriaan A Voors; Dirk J van Veldhuisen
Treatment of heart failure with ACE inhibitors and beta-blockers: what is next? Aldosterone receptor antagonists?
Clinical research in cardiology : official journal of the German Cardiac Society 2007;96(4):193-5.
2007: Igor I Tulevski; Marije ten Wolde; Dirk J van Veldhuisen; Jasper W M Mulder; Ernst E van der Wall; Harry R Büller; Barbara J M Mulder
Combined utility of brain natriuretic peptide and cardiac troponin T may improve rapid triage and risk stratification in normotensive patients with pulmonary embolism.
International journal of cardiology 2007;116(2):161-6.
2007: Ans C P Wiesfeld; Maarten P van den Berg; J Peter van Tintelen; Dirk J van Veldhuisen
[Cardiogenetics: the importance of identifying patients with hereditary heart disease].
Nederlands tijdschrift voor geneeskunde 2007;151(11):627-9.
2007: Daniela Dobre; Mike J L DeJongste; Carolien Lucas; Ger Cleuren; Dirk J van Veldhuisen; Adelita Ranchor; Flora M Haaijer-Ruskamp
Effectiveness of beta-blocker therapy in daily practice patients with advanced chronic heart failure; is there an effect-modification by age?
British journal of clinical pharmacology 2007;63(3):356-64.
2007: Michiel Rienstra; Dirk J van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder
Enhanced cardiovascular morbidity and mortality during rhythm control treatment in persistent atrial fibrillation in hypertensives: data of the RACE study.
European heart journal 2007;28(6):741-51.
2007: Daniela Dobre; Dirk J van Veldhuisen; Mike J L DeJongste; Carolien Lucas; Ger Cleuren; Robbert Sanderman; Adelita Ranchor; Flora M Haaijer-Ruskamp
Prescription of beta-blockers in patients with advanced heart failure and preserved left ventricular ejection fraction. Clinical implications and survival.
European journal of heart failure 2007;9(3):280-6.
2007: Dirk J van Veldhuisen; john mcmurray
Are erythropoietin stimulating proteins safe and efficacious in heart failure? Why we need an adequately powered randomised outcome trial.
European journal of heart failure 2007;9(2):110-2.
2007: Patrick J Perik; Elisabeth G E de Vries; Jourik A Gietema; Winette T A van der Graaf; Tom D J Smilde; Dirk T Sleijfer; Dirk J van Veldhuisen
Serum HER2 levels are increased in patients with chronic heart failure.
European journal of heart failure 2007;9(2):173-7.
2007: Daniela Dobre; Flora M Haaijer-Ruskamp; Adriaan A Voors; Dirk J van Veldhuisen
beta-Adrenoceptor antagonists in elderly patients with heart failure: a critical review of their efficacy and tolerability.
Drugs & aging 2007;24(12):1031-44.
2007: Arend Bergstra; Tone Svilaas; Dirk J van Veldhuisen; Ad F M van den Heuvel; Iwan C C van der Horst; Felix Zijlstra
Haemodynamic patterns in ST-elevation myocardial infarction: incidence and correlates of elevated filling pressures.
Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation 2007;15(3):95-9.
2007: Michiel Rienstra; Marcelle D Smit; Wybe Nieuwland; Eng S Tan; Ans C P Wiesfeld; Rutger L Anthonio; Maarten P van den Berg; Dirk J van Veldhuisen; Isabelle C Van Gelder
Persistent atrial fibrillation is associated with appropriate shocks and heart failure in patients with left ventricular dysfunction treated with an implantable cardioverter defibrillator.
American heart journal 2007;153(1):120-6.
2007: B Daan Westenbrink; Folkert W Visser; Adriaan A Voors; Tom D J Smilde; Erik Lipsic; gerjan navis; Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen
Anaemia in chronic heart failure is not only related to impaired renal perfusion and blunted erythropoietin production, but to fluid retention as well.
European heart journal 2007;28(2):166-71.
2007: Faiez Zannad; Etienne Huvelle; Kenneth Dickstein; Dirk J van Veldhuisen; Christoph Stellbrink; Lars Køber; Serge Cazeau; Philippe Ritter; Aldo P Maggioni; Roberto Ferrari; Philippe Lechat
Left bundle branch block as a risk factor for progression to heart failure.
European journal of heart failure 2007;9(1):7-14.
2006: Erik Lipsic; Regien G Schoemaker; peter van der meer; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Protective effects of erythropoietin in cardiac ischemia: from bench to bedside.
Journal of the American College of Cardiology 2006;48(11):2161-7.
2006: Marcelle D Smit; Pascal F H M van Dessel; Wybe Nieuwland; Ans C P Wiesfeld; Eng S Tan; Rutger L Anthonio; Lieselot van Erven; Dirk J van Veldhuisen; Isabelle C Van Gelder
Right ventricular pacing and the risk of heart failure in implantable cardioverter-defibrillator patients.
Heart rhythm : the official journal of the Heart Rhythm Society 2006;3(12):1397-403.
2006: Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; A C M Schmidt; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Krystyna M Sollie; Adriaan A Voors; Tjark Ebels; Dirk J van Veldhuisen
Non-cardiac complications during pregnancy in women with isolated congenital pulmonary valvar stenosis.
Heart (British Cardiac Society) 2006;92(12):1838-43.
2006: Marco J W Götte; Tjeerd Germans; Iris Rüssel; Jaco Zwanenburg; J Tim Marcus; Albert C van Rossum; Dirk J van Veldhuisen
Myocardial strain and torsion quantified by cardiovascular magnetic resonance tissue tagging: studies in normal and impaired left ventricular function.
Journal of the American College of Cardiology 2006;48(10):2002-11.
2006: Dirk J van Veldhuisen; M I Koopmans; T Jaarsma
[The nurse practitioner in the treatment of cardiac patients: successful job reallocation within health care].
Nederlands tijdschrift voor geneeskunde 2006;150(46):2528-9.
2006: Rudolf A de Boer; Maarten P van den Berg; Dirk J van Veldhuisen
Genetics in heart failure: where are we headed?
Congestive heart failure (Greenwich, Conn.) 2006;12(6):329-32.
2006: Bas A Schoonderwoerd; Ans C P Wiesfeld; Arthur A M Wilde; Freek van den Heuvel; J Peter van Tintelen; Maarten P van den Berg; Dirk J van Veldhuisen; Isabelle C Van Gelder
A family with Andersen-Tawil syndrome and dilated cardiomyopathy.
Heart rhythm : the official journal of the Heart Rhythm Society 2006;3(11):1346-50.
2006: Ruud M A van de Wal; Ron T Gansevoort; Pim van der Harst; Frans Boomsma; H W Thijs Plokker; Dirk J van Veldhuisen; Paul E de Jong; Wiek H van Gilst; Adriaan A Voors
Predictors of angiotensin-converting enzyme inhibitor-induced reduction of urinary albumin excretion in nondiabetic patients.
Hypertension 2006;48(5):870-6.
2006: Cornelia H M van Jaarsveld; Adelita Ranchor; Gertrudis I J M Kempen; James C Coyne; Dirk J van Veldhuisen; Johan Ormel; Robbert Sanderman
Gender-specific risk factors for mortality associated with incident coronary heart disease--a prospective community-based study.
Preventive medicine 2006;43(5):361-7.
2006: Isabelle C Van Gelder; Marcelle D Smit; Wybe Nieuwland; Dirk J van Veldhuisen
[Non-pharmacological treatment of heart failure: implantable cardioverter defibrillator (ICD) and cardiac resynchronisation therapy].
Nederlands tijdschrift voor geneeskunde 2006;150(41):2238-44.
2006: Tom D J Smilde; Dirk J van Veldhuisen; gerjan navis; Adriaan A Voors; Hans L Hillege
Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.
Circulation 2006;114(15):1572-80.
2006: Bertram Pitt; Roberto Ferrari; Mihai Gheorghiade; Dirk J van Veldhuisen; Henry Krum; john mcmurray; Jose Lopez-Sendon
Aldosterone blockade in post-acute myocardial infarction heart failure.
Clinical cardiology 2006;29(10):434-8.
2006: Vincent E Hagens; Michiel Rienstra; Dirk J van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder
Determinants of sudden cardiac death in patients with persistent atrial fibrillation in the rate control versus electrical cardioversion (RACE) study.
The American journal of cardiology 2006;98(7):929-32.
2006: Ivonne Lesman-Leegte; Tiny Jaarsma; Robbert Sanderman; Gerard Linssen; Dirk J van Veldhuisen
Depressive symptoms are prominent among elderly hospitalised heart failure patients.
European journal of heart failure 2006;8(6):634-40.
2006: Pim van der Harst; Folkert Asselbergs; Hendrik Buikema; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of C-reactive protein and cholesterol on responsiveness in vitro of the internal thoracic artery to angiotensin II in patients having coronary artery bypass grafting.
The American journal of cardiology 2006;98(6):751-3.
2006: Martin E W Hemels; Trudeke Van Noord; Harry J G M Crijns; Dirk J van Veldhuisen; Nic J G M Veeger; Hans A Bosker; Ans C P Wiesfeld; Maarten P van den Berg; Adelita Ranchor; Isabelle C Van Gelder
Verapamil versus digoxin and acute versus routine serial cardioversion for the improvement of rhythm control for persistent atrial fibrillation.
Journal of the American College of Cardiology 2006;48(5):1001-9.
2006: Patrick J Perik; Elisabeth G E de Vries; Frans Boomsma; Juergen Messerschmidt; Dirk J van Veldhuisen; Dirk T Sleijfer; Jourik A Gietema; Winette T A van der Graaf
The relation between soluble apoptotic proteins and subclinical cardiotoxicity in adjuvant-treated breast cancer patients.
Anticancer research 2006;26(5B):3803-11.
2006: Isabelle C Van Gelder; Dirk J van Veldhuisen; Harry J G M Crijns; Ype S Tuininga; Jan G P Tijssen; A Marco Alings; Hans A Bosker; Jan H Cornel; Otto Kamp; Nic J G M Veeger; Meint Volbeda; Michiel Rienstra; Adelita Ranchor; Elisabeth M TenVergert; Maarten P van den Berg
RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II.
American heart journal 2006;152(3):420-6.
2006: Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; W A van Lottum; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Krystyna M Sollie; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Pregnancy and delivery in women after Fontan palliation.
Heart (British Cardiac Society) 2006;92(9):1290-4.
2006: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Michael Böhm; Dirk J van Veldhuisen
Statins in the treatment of chronic heart failure: a systematic review.
PLoS medicine 2006;3(8):e333.
2006: Riemer H J A Slart; Ali Agool; Dirk J van Veldhuisen; Rudi A Dierckx; Jeroen J Bax
Nitrate administration increases blood flow in dysfunctional but viable myocardium, leading to improved assessment of myocardial viability: A PET study.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2006;47(8):1307-11.
2006: Marcelle D Smit; Pascal F H M van Dessel; Michiel Rienstra; Wybe Nieuwland; Ans C P Wiesfeld; Eng S Tan; Rutger L Anthonio; Dirk J van Veldhuisen; Isabelle C Van Gelder
Atrial fibrillation predicts appropriate shocks in primary prevention implantable cardioverter-defibrillator patients.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2006;8(8):566-72.
2006: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Michael Böhm; Dirk J van Veldhuisen
Statins in the treatment of chronic heart failure: biological and clinical considerations.
Cardiovascular research 2006;71(3):443-54.
2006: Dirk J van Veldhuisen; Halfdan Aass; Dia el Allaf; Peter H J M Dunselman; Lars Gullestad; Matti Halinen; John Kjekshus; Lis Ohlsson; Hans Wedel; John Wikstrand
Presence and development of atrial fibrillation in chronic heart failure. Experiences from the MERIT-HF Study.
European journal of heart failure 2006;8(5):539-46.
2006: Martin E W Hemels; Maarten P van den Berg; Adelita Ranchor; Eric van Sonderen; Isabelle C Van Gelder; Dirk J van Veldhuisen
Predictors of non-pharmacological intervention in patients with paroxysmal atrial fibrillation: Value of neuroticism.
International journal of cardiology 2006;111(1):75-9.
2006: Willem Drenthen; Petronella G Pieper; Nicole Zoon; Jolien Roos-Hesselink; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Krystyna M Sollie; Hubert W Vliegen; Tjark Ebels; Dirk J van Veldhuisen
Pregnancy after biventricular repair for pulmonary atresia with ventricular septal defect.
The American journal of cardiology 2006;98(2):262-6.
2006: Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; Nicole Zoon; Adriaan A Voors; Barbara J M Mulder; Arie P J van Dijk; Hubert W Vliegen; Krystyna M Sollie; Tjark Ebels; Dirk J van Veldhuisen
Fertility, pregnancy, and delivery after biventricular repair for pulmonary atresia with an intact ventricular septum.
The American journal of cardiology 2006;98(2):259-61.
2006: Paul L van Haelst; Johan Brügemann; Gilles F Diercks; Albert Suurmeijer; Dirk J van Veldhuisen
Serial right ventricular endomyocardial biopsy in rapid-onset severe heart failure due to giant cell myocarditis.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2006;15(4):228-30.
2006: Michiel Rienstra; Isabelle C Van Gelder; Maarten P van den Berg; Frans Boomsma; Dirk J van Veldhuisen
Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2006;8(7):482-7.
2006: Pim van der Harst; Adriaan A Voors; Meint Volbeda; Hendrik Buikema; Dirk J van Veldhuisen; Wiek H van Gilst
Usefulness of preoperative C-reactive protein and soluble intercellular adhesion molecule-1 level for predicting future cardiovascular events after coronary artery bypass grafting.
The American journal of cardiology 2006;97(12):1697-701.
2006: Lilian J Meijboom; Willem Drenthen; Petronella G Pieper; Maarten Groenink; Joris A M van der Post; Janneke Timmermans; Adriaan A Voors; Jolien Roos-Hesselink; Dirk J van Veldhuisen; Barbara J M Mulder
Obstetric complications in Marfan syndrome.
International journal of cardiology 2006;110(1):53-9.
2006: john mcmurray; Fredrik L Andersson; Simon Stewart; Klas Svensson; Alain Cohen Solal; Rainer Dietz; Johan Vanhaecke; Dirk J van Veldhuisen; Jan Ostergren; Christopher B Granger; Salim Yusuf; Marc A Pfeffer; Karl Swedberg
Resource utilization and costs in the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.
European heart journal 2006;27(12):1447-58.
2006: Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Roy Irwan; Wim J Sluiter; Rudi A Dierckx; Jaep de Boer; Pieter L Jager
Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
European journal of nuclear medicine and molecular imaging 2006;33(6):716-23.
2006: Mihai Gheorghiade; Dirk J van Veldhuisen; Wilson S Colucci
Contemporary use of digoxin in the management of cardiovascular disorders.
Circulation 2006;113(21):2556-64.
2006: Patrick J Perik; Marjolijn N Lub-de Hooge; Jourik A Gietema; Winette T A van der Graaf; Maarten Alexander de Korte; Sharon Jonkman; Jos G W Kosterink; Dirk J van Veldhuisen; Dirk T Sleijfer; Pieter L Jager; Elisabeth G E de Vries
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(15):2276-82.
2006: Michiel Rienstra; Ans C P Wiesfeld; Dirk J van Veldhuisen; Isabelle C Van Gelder
[Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
Nederlands tijdschrift voor geneeskunde 2006;150(18):1027-31.
2006: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Hans L Hillege; Arno Hoes; Dirk J van Veldhuisen
Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
American heart journal 2006;151(5):1012.e1-5.
2006: Martin E W Hemels; Youlan L Gu; Anton E Tuinenburg; Piet W Boonstra; Ans C P Wiesfeld; Maarten P van den Berg; Dirk J van Veldhuisen; Isabelle C Van Gelder
Favorable long-term outcome of Maze surgery in patients with lone atrial fibrillation.
The Annals of thoracic surgery 2006;81(5):1773-9.
2006: Bertram Pitt; Mihai Gheorghiade; Faiez Zannad; Jeffrey L Anderson; Dirk J van Veldhuisen; Alexander Parkhomenko; Ramon Corbalan; Eric Q Klug; Robin Mukherjee; Henry Solomon
Evaluation of eplerenone in the subgroup of EPHESUS patients with baseline left ventricular ejection fraction
European journal of heart failure 2006;8(3):295-301.

2006: Joost P van Melle; Peter de Jonge; Astrid M G Kuyper; Adriaan Honig; Aart H Schene; Harry J G M Crijns; Maarten P van den Berg; Dirk J van Veldhuisen; Johan Ormel
Prediction of depressive disorder following myocardial infarction data from the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).
International journal of cardiology 2006;109(1):88-94.
2006: Michiel Rienstra; Isabelle C Van Gelder; Maarten P van den Berg; Frans Boomsma; Hans L Hillege; Dirk J van Veldhuisen
A comparison of low versus high heart rate in patients with atrial fibrillation and advanced chronic heart failure: effects on clinical profile, neurohormones and survival.
International journal of cardiology 2006;109(1):95-100.
2006: Erik Lipsic; peter van der meer; Adriaan A Voors; B Daan Westenbrink; Ad F M van den Heuvel; Hetty C de Boer; Anton-Jan van Zonneveld; Regien G Schoemaker; Wiek H van Gilst; Felix Zijlstra; Dirk J van Veldhuisen
A single bolus of a long-acting erythropoietin analogue darbepoetin alfa in patients with acute myocardial infarction: a randomized feasibility and safety study.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(2):135-41.
2006: Vincent E Hagens; Dirk J van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder
Implication from randomized trials of rate and rhythm controls on management of patients with persistent atrial fibrillation.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2006;11(2):170-86.
2006: Riemer H J A Slart; Pieter L Jager; Dirk J van Veldhuisen; Jeroen J Bax
Optimal imaging of patients with ischaemic heart failure.
Nuclear medicine communications 2006;27(4):317-20.
2006: Jochem Hogenhuis; Tiny Jaarsma; Adriaan A Voors; Hans L Hillege; Ivonne Lesman; Dirk J van Veldhuisen
Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
International journal of cardiology 2006;108(1):63-7.
2006: Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A Dierckx; Jaep de Boer; Pieter L Jager
Prediction of functional recovery after revascularization in patients with coronary artery disease and left ventricular dysfunction by gated FDG-PET.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2006;13(2):210-9.
2006: Ronnie Willenheimer; Henry Krum; Dirk J van Veldhuisen; Christian Funck-Brentano; Erland Erdmann; Wilfried R Meyer
Comment on "Clinical trials update from the European Society of Cardiology meeting 2005: CIBIS-III, by JGF Cleland and others".
European journal of heart failure 2006;8(2):219-20.
2006: Bart Westendorp; Regien G Schoemaker; Hendrik Buikema; Frans Boomsma; Dirk J van Veldhuisen; Wiek H van Gilst
Progressive left ventricular hypertrophy after withdrawal of long-term ACE inhibition following experimental myocardial infarction.
European journal of heart failure 2006;8(2):122-30.
2006: Tom D J Smilde; Hans L Hillege; gerjan navis; Adriaan A Voors; Jan Brouwer; Dirk J van Veldhuisen
Difference in long-term prognostic value of renal function between ischemic and non-ischemic mild heart failure.
International journal of cardiology 2006;107(1):73-7.
2006: Hans L Hillege; Dorothea Nitsch; Marc A Pfeffer; Karl Swedberg; john mcmurray; Salim Yusuf; Christopher B Granger; Eric L Michelson; Jan Ostergren; Jan Hein Cornel; Dick De Zeeuw; Stuart Pocock; Dirk J van Veldhuisen
Renal function as a predictor of outcome in a broad spectrum of patients with heart failure.
Circulation 2006;113(5):671-8.
2006: Martin E W Hemels; Ans C P Wiesfeld; Bas Inberg; Pascal F H M van Dessel; Wybe Nieuwland; Eng S Tan; Henk Mulder; Dirk J van Veldhuisen; Isabelle C Van Gelder
Right atrial overdrive pacing for prevention of symptomatic refractory atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2006;8(2):107-12.
2006: Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst
The current role of ACE-inhibitors for secondary prevention in cardiovascular disease; from pathogenesis to clinical practice.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2006;20(1):69-73.
2006: Riemer H J A Slart; Jeroen J Bax; Dirk J van Veldhuisen; Ernst E van der Wall; Rudi A Dierckx; Pieter L Jager
Imaging techniques in nuclear cardiology for the assessment of myocardial viability.
The international journal of cardiovascular imaging 2006;22(1):63-80.
2006: Pim van der Harst; Tom D J Smilde; Hendrik Buikema; Adriaan A Voors; gerjan navis; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular function and mild renal impairment in stable coronary artery disease.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(2):379-84.
2006: Michiel Rienstra; Isabelle C Van Gelder; Vincent E Hagens; Nic J G M Veeger; Dirk J van Veldhuisen; Harry J G M Crijns
Mending the rhythm does not improve prognosis in patients with persistent atrial fibrillation: a subanalysis of the RACE study.
European heart journal 2006;27(3):357-64.
2006: Martje H L van der Wal; Tiny Jaarsma; Debra Moser; Nic J G M Veeger; Wiek H van Gilst; Dirk J van Veldhuisen
Compliance in heart failure patients: the importance of knowledge and beliefs.
European heart journal 2006;27(4):434-40.
2006: Ruud M A van de Wal; H W M Plokker; D J A Lok; F Boomsma; F A L van der Horst; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
International journal of cardiology 2006;106(3):367-72.
2006: Erik Lipsic; Adriaan A Voors; Dirk J van Veldhuisen
Serum erythropoietin levels and infarct size.
Journal of the American College of Cardiology 2006;47(2):468-9; author reply 469-70.
2006: Joost P van Melle; Peter de Jonge; Maarten P van den Berg; Harm J Pot; Dirk J van Veldhuisen
Treatment of depression in acute coronary syndromes with selective serotonin reuptake inhibitors.
Drugs 2006;66(16):2095-107.
2006: Patrick J Perik; Winette T A van der Graaf; Elisabeth G E de Vries; Frans Boomsma; Juergen Messerschmidt; Dirk J van Veldhuisen; Dirk T Sleijfer; Jourik A Gietema
Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors.
Acta oncologica (Stockholm, Sweden) 2006;45(2):175-83.
2006: Marie Louise Luttik; Tiny Jaarsma; Nic J G M Veeger; Dirk J van Veldhuisen
Marital status, quality of life, and clinical outcome in patients with heart failure.
Heart & lung : the journal of critical care 2006;35(1):3-8.
2006: Peter de Jonge; Johan Ormel; Rob H S van den Brink; Joost P van Melle; Titia A Spijkerman; Astrid Kuijper; Dirk J van Veldhuisen; Maarten P van den Berg; Adriaan Honig; Harry J G M Crijns; Aart H Schene
Symptom dimensions of depression following myocardial infarction and their relationship with somatic health status and cardiovascular prognosis.
The American journal of psychiatry 2006;163(1):138-44.
2006: Dirk J van Veldhuisen; Harry J G M Crijns; Maarten P van den Berg
Heart failure, atrial fibrillation, and beta-blockers.
European heart journal 2006;27(2):247.
2006: Cornelia H M van Jaarsveld; Adelita Ranchor; Gertrudis I J M Kempen; James C Coyne; Dirk J van Veldhuisen; Robbert Sanderman
Epidemiology of heart failure in a community-based study of subjects aged > or = 57 years: incidence and long-term survival.
European journal of heart failure 2006;8(1):23-30.
2005: Bart Westendorp; Regien G Schoemaker; Wiek H van Gilst; Dirk J van Veldhuisen; Hendrik Buikema
Hydrochlorothiazide increases plasma or tissue angiotensin-converting enzyme-inhibitor drug levels in rats with myocardial infarction: differential effects on lisinopril and zofenopril.
European journal of pharmacology 2005;527(1-3):141-9.
2005: Adriaan A Voors; Peter P van Geel; Hendrik Buikema; Margreeth Oosterga; Dirk J van Veldhuisen; Wiek H van Gilst
High angiotensin II responsiveness is associated with decreased endothelium-dependent relaxation in human arteries.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2005;6(3):145-50.
2005: Bart Westendorp; Regien G Schoemaker; Hendrik Buikema; Dick De Zeeuw; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen
Beneficial effects of add-on hydrochlorothiazide in rats with myocardial infarction optimally treated with quinapril.
European journal of heart failure 2005;7(7):1085-94.
2005: Joost P van Melle; Peter de Jonge; Johan Ormel; Harry J G M Crijns; Dirk J van Veldhuisen; Adriaan Honig; Aart H Schene; Maarten P van den Berg
Relationship between left ventricular dysfunction and depression following myocardial infarction: data from the MIND-IT.
European heart journal 2005;26(24):2650-6.
2005: Willem Drenthen; Petronella G Pieper; Martine Ploeg; Adriaan A Voors; Jolien Roos-Hesselink; Barbara J M Mulder; Hubert W Vliegen; Krystyna M Sollie; Tjark Ebels; Dirk J van Veldhuisen
Risk of complications during pregnancy after Senning or Mustard (atrial) repair of complete transposition of the great arteries.
European heart journal 2005;26(23):2588-95.
2005: Martje H L van der Wal; Tiny Jaarsma; Debra Moser; Dirk J van Veldhuisen
Development and testing of the Dutch Heart Failure Knowledge Scale.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2005;4(4):273-7.
2005: Willem Drenthen; Petronella G Pieper; Karin van der Tuuk; Jolien Roos-Hesselink; Adriaan A Voors; Bianca Mostert; Barbara J M Mulder; Philip Moons; Tjark Ebels; Dirk J van Veldhuisen
Cardiac complications relating to pregnancy and recurrence of disease in the offspring of women with atrioventricular septal defects.
European heart journal 2005;26(23):2581-7.
2005: Pim van der Harst; Lodewijk J Wagenaar; Hendrik Buikema; Adriaan A Voors; H W M Plokker; Wim J Morshuis; A Jacob Six; Piet W Boonstra; Georg Nickenig; Sven Wassmann; Dirk J van Veldhuisen; Wiek H van Gilst
Effect of intensive versus moderate lipid lowering on endothelial function and vascular responsiveness to angiotensin II in stable coronary artery disease.
The American journal of cardiology 2005;96(10):1361-4.
2005: Tom D J Smilde; G C M Linssen; D Gallemann; T Kuhn; T Machnig; Peter G M Mol; Hans L Hillege; LM van Wijk; RB van Dijk; Dirk J van Veldhuisen
Influence of renal dysfunction on the pharmacokinetics of the selective Na+/H+ exchange inhibitor EMD 87 580 in patients with chronic heart failure.
International journal of clinical pharmacology and therapeutics 2005;43(11):507-16.
2005: Bas A Schoonderwoerd; Isabelle C Van Gelder; Dirk J van Veldhuisen; Maarten P van den Berg; Harry J G M Crijns
Electrical and structural remodeling: role in the genesis and maintenance of atrial fibrillation.
Progress in cardiovascular diseases 2005;48(3):153-68.
2005: Darlington O Okonko; Dirk J van Veldhuisen; Philip A Poole-Wilson; Stefan D Anker
Anaemia of chronic disease in chronic heart failure: the emerging evidence.
European heart journal 2005;26(21):2213-4.
2005: Ruud M A van de Wal; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
Addition of an angiotensin receptor blocker to full-dose ACE-inhibition: controversial or common sense?
European heart journal 2005;26(22):2361-7.
2005: Adriaan A Voors; Willem F Terpstra; Andries J Smit; Frank W Beltman; R Vijn; Pieter A de Graeff; Dirk J van Veldhuisen
Gender-related differences in left ventricular structural and functional responses to hypertension.
Journal of human hypertension 2005;19(11):915-7.
2005: Ronnie Willenheimer; Dirk J van Veldhuisen; Bernard Silke; Erland Erdmann; Ferenc Follath; Henry Krum; Piotr Ponikowski; Allan Skene; Louis van de Ven; Patricia Verkenne; Philippe Lechat
Effect on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril, as compared with the opposite sequence: results of the randomized Cardiac Insufficiency Bisoprolol Study (CIBIS) III.
Circulation 2005;112(16):2426-35.
2005: Michiel Rienstra; Dirk J van Veldhuisen; Vincent E Hagens; Adelita Ranchor; Nic J G M Veeger; Harry J G M Crijns; Isabelle C Van Gelder
Gender-related differences in rhythm control treatment in persistent atrial fibrillation: data of the Rate Control Versus Electrical Cardioversion (RACE) study.
Journal of the American College of Cardiology 2005;46(7):1298-306.
2005: Ruud M A van de Wal; Folkert Asselbergs; H W M Plokker; Tom D J Smilde; Dirk Lok; Dirk J van Veldhuisen; Wiek H van Gilst; Adriaan A Voors
High prevalence of microalbuminuria in chronic heart failure patients.
Journal of cardiac failure 2005;11(8):602-6.
2005: Joris W J Vriend; Willem Drenthen; Petronella G Pieper; Jolien Roos-Hesselink; Aeiko H Zwinderman; Dirk J van Veldhuisen; Barbara J M Mulder
Outcome of pregnancy in patients after repair of aortic coarctation.
European heart journal 2005;26(20):2173-8.
2005: peter van der meer; Erik Lipsic; B Daan Westenbrink; Ruud M A van de Wal; Regien G Schoemaker; Edo Vellenga; Dirk J van Veldhuisen; Adriaan A Voors; Wiek H van Gilst
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure.
Circulation 2005;112(12):1743-7.
2005: Patrick J Perik; E G E de Vries; Frans Boomsma; Winette T A van der Graaf; Dirk T Sleijfer; Dirk J van Veldhuisen; Jourik A Gietema
Use of natriuretic peptides for detecting cardiac dysfunction in long-term disease-free breast cancer survivors.
Anticancer research 2005;25(5):3651-7.
2005: Adriaan A Voors; Colin J Petrie; Mark C Petrie; Andrew Charlesworth; Hans L Hillege; Felix Zijlstra; John J McMurray; Dirk J van Veldhuisen
Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
European heart journal 2005;26(17):1759-64.
2005: Ans C P Wiesfeld; Martin E W Hemels; J Peter van Tintelen; Maarten P van den Berg; Dirk J van Veldhuisen; Isabelle C Van Gelder
Genetic aspects of atrial fibrillation.
Cardiovascular research 2005;67(3):414-8.
2005: Bertram Pitt; Harvey White; Jose Nicolau; Felipe Martinez; Mihai Gheorghiade; Michael Aschermann; Dirk J van Veldhuisen; Faiez Zannad; Henry Krum; Robin Mukherjee; John Vincent
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure.
Journal of the American College of Cardiology 2005;46(3):425-31.
2005: Pieta W F Bruggink-André de la Porte; Dirk J A Lok; Jan van Wijngaarden; Jan H Cornel; Dian Pruijsers-Lamers; Dirk J van Veldhuisen; Arno Hoes
Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study.
European journal of heart failure 2005;7(5):910-20.
2005: Patrick J Perik; Dirk J van Veldhuisen; Jourik A Gietema
Natriuretic peptides in anthracycline-induced cardiotoxicity.
European journal of heart failure 2005;7(5):940-1; author reply 941.
2005: Michel Komajda; Pablo Lapuerta; Nancy Hermans; José Ramon Gonzalez-Juanatey; Dirk J van Veldhuisen; Erland Erdmann; Luigi Tavazzi; Philip A Poole-Wilson; Claude Le Pen
Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey.
European heart journal 2005;26(16):1653-9.
2005: Riemer H J A Slart; Jeroen J Bax; Jaep de Boer; Antoon T M Willemsen; Piet H Mook; Matthijs Oudkerk; Ernst E van der Wall; Dirk J van Veldhuisen; Pieter L Jager
Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
European journal of nuclear medicine and molecular imaging 2005;32(8):972-9.
2005: Ronnie Willenheimer; Dirk J van Veldhuisen; Piotr Ponikowski; Philippe Lechat
Beta-blocker treatment before angiotensin-converting enzyme inhibitor therapy in newly diagnosed heart failure.
Journal of the American College of Cardiology 2005;46(1):182.
2005: peter van der meer; Erik Lipsic; Robert H Henning; Kristien M Boddeus; Jolanda van der Velden; Adriaan A Voors; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction.
Journal of the American College of Cardiology 2005;46(1):125-33.
2005: John R Teerlink; john mcmurray; Robert Bourge; John G F Cleland; Gad Cotter; Guillaume Jondeau; Henry Krum; Marco Metra; Christopher M O'Connor; John D Parker; Guillermo Torre Amione; Dirk J van Veldhuisen; Aline Frey; Maurizio Rainisio; Isaac Kobrin
Tezosentan in patients with acute heart failure: design of the Value of Endothelin Receptor Inhibition with Tezosentan in Acute heart failure Study (VERITAS).
American heart journal 2005;150(1):46-53.
2005: Tom D J Smilde; Hans L Hillege; Dirk J van Veldhuisen; gerjan navis
Angiotensin-converting enzyme inhibitors and outcome among patients with heart failure and renal insufficiency: need for a prospective study.
Journal of the American College of Cardiology 2005;45(11):1905.
2005: Vincent E Hagens; Harry J G M Crijns; Dirk J van Veldhuisen; Maarten P van den Berg; Michiel Rienstra; Adelita Ranchor; Hans A Bosker; Otto Kamp; Jan G P Tijssen; Nic J G M Veeger; Isabelle C Van Gelder
Rate control versus rhythm control for patients with persistent atrial fibrillation with mild to moderate heart failure: results from the RAte Control versus Electrical cardioversion (RACE) study.
American heart journal 2005;149(6):1106-11.
2005: J M Meijer; Petronella G Pieper; Willem Drenthen; Adriaan A Voors; Jolien Roos-Hesselink; Arie P J van Dijk; Barbara J M Mulder; Tjark Ebels; Dirk J van Veldhuisen
Pregnancy, fertility, and recurrence risk in corrected tetralogy of Fallot.
Heart (British Cardiac Society) 2005;91(6):801-5.
2005: Dirk J van Veldhuisen; Adriaan A Voors
Implantable cardioverter-defibrillators.
The New England journal of medicine 2005;352(19):2022-5; author reply 2022-5.
2005: Pim van der Harst; Adriaan A Voors; Wiek H van Gilst; Dirk J van Veldhuisen
Statins and autonomic function in chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(3):167-8.
2005: peter van der meer; Rudolf A de Boer; Hazel L White; Gerrit van der Steege; Alistair Hall; Adriaan A Voors; Dirk J van Veldhuisen
The VEGF +405 CC promoter polymorphism is associated with an impaired prognosis in patients with chronic heart failure: a MERIT-HF substudy.
Journal of cardiac failure 2005;11(4):279-84.
2005: Marie Louise Luttik; Tiny Jaarsma; Debra Moser; Robbert Sanderman; Dirk J van Veldhuisen
The importance and impact of social support on outcomes in patients with heart failure: an overview of the literature.
The Journal of cardiovascular nursing 2005;20(3):162-9.
2005: Erik Lipsic; Iwan C C van der Horst; Adriaan A Voors; peter van der meer; Maarten W N Nijsten; Wiek H van Gilst; Dirk J van Veldhuisen; Felix Zijlstra
Hemoglobin levels and 30-day mortality in patients after myocardial infarction.
International journal of cardiology 2005;100(2):289-92.
2005: Dirk J van Veldhuisen; Pascal F H M van Dessel
Cardiac resynchronization therapy in chronic heart failure: how to select the patient that will benefit?
International journal of cardiology 2005;100(1):13-5.
2005: Richard M de Jong; Antoon T M Willemsen; Riemer H J A Slart; Paul K Blanksma; Aren van Waarde; Jan Hein Cornel; Willem Vaalburg; Dirk J van Veldhuisen; Philip H Elsinga
Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388.
European journal of nuclear medicine and molecular imaging 2005;32(4):443-7.
2005: Tiny Jaarsma; Flora M Haaijer-Ruskamp; Heidrun B Sturm; Dirk J van Veldhuisen
Management of heart failure in The Netherlands.
European journal of heart failure 2005;7(3):371-5.
2005: Adriaan A Voors; Pieter J de Kam; Maarten P van den Berg; Claudio Borghi; Judith S Hochman; Dirk J van Veldhuisen; Wiek H van Gilst
Acute administration of angiotensin converting enzyme inhibitors in thrombolysed myocardial infarction patients is associated with a decreased incidence of heart failure, but an increased re-infarction risk.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(2):119-24.
2005: Tom D J Smilde; Folkert Asselbergs; Hans L Hillege; Adriaan A Voors; Jan A Kors; Ron T Gansevoort; Wiek H van Gilst; Paul E de Jong; Dirk J van Veldhuisen
Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy.
American journal of hypertension 2005;18(3):342-7.
2005: Marie Louise Luttik; Tiny Jaarsma; Nic J G M Veeger; Dirk J van Veldhuisen
For better and for worse: Quality of life impaired in HF patients as well as in their partners.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2005;4(1):11-4.
2005: Ivonne Lesman-Leegte; Tiny Jaarsma; Dirk J van Veldhuisen
Quality of life in patients with preserved and depressed left ventricular function.
European heart journal 2005;26(5):525-6; author reply 526.
2005: Patrick J Perik; Elisabeth G E de Vries; Jourik A Gietema; Winette T A van der Graaf; Dirk T Sleijfer; Albert J H Suurmeijer; Dirk J van Veldhuisen
The dilemma of the strive for apoptosis in oncology: mind the heart.
Critical reviews in oncology/hematology 2005;53(2):101-13.
2005: Marcus Flather; Marcelo C Shibata; Andrew J S Coats; Dirk J van Veldhuisen; Aleksandr Parkhomenko; Joszef Borbola; Alain Cohen-Solal; Dan Dumitrascu; Roberto Ferrari; Philippe Lechat; Jordi Soler-Soler; Luigi Tavazzi; Lenka Spinarova; Jirí Toman; Michael Böhm; Stefan D Anker; Simon G Thompson; Philip A Poole-Wilson
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).
European heart journal 2005;26(3):215-25.
2005: Rudolf A de Boer; Hans L Hillege; Geert Tjeerdsma; Freek W A Verheugt; Dirk J van Veldhuisen
Both antiplatelet and anticoagulant therapy may favorably affect outcome in patients with advanced heart failure. A retrospective analysis of the PRIME-II trial.
Thrombosis research 2005;116(4):279-85.
2005: peter van der meer; Erik Lipsic; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoietin: from hematopoiesis to cardioprotection.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2005;19(1):7-8.
2005: Vincent E Hagens; Dirk J van Veldhuisen; Otto Kamp; Michiel Rienstra; Hans A Bosker; Nic J G M Veeger; Jan G P Tijssen; Harry J G M Crijns; Isabelle C Van Gelder
Effect of rate and rhythm control on left ventricular function and cardiac dimensions in patients with persistent atrial fibrillation: results from the RAte Control versus Electrical Cardioversion for Persistent Atrial Fibrillation (RACE) study.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(1):19-24.
2005: Folkert Asselbergs; Maarten P van den Berg; Gilles F H Diercks; Wiek H van Gilst; Dirk J van Veldhuisen
C-reactive protein and microalbuminuria are associated with atrial fibrillation.
International journal of cardiology 2005;98(1):73-7.
2005: Trudeke Van Noord; Harry J G M Crijns; Maarten P van den Berg; Dirk J van Veldhuisen; Isabelle C Van Gelder
Pretreatment with ACE inhibitors improves acute outcome of electrical cardioversion in patients with persistent atrial fibrillation.
BMC cardiovascular disorders 2005;5(1):3.
2005: Jochem Hogenhuis; Adriaan A Voors; Tiny Jaarsma; Hans L Hillege; Frans Boomsma; Dirk J van Veldhuisen
Influence of age on natriuretic peptides in patients with chronic heart failure: a comparison between ANP/NT-ANP and BNP/NT-proBNP.
European journal of heart failure 2005;7(1):81-6.
2005: Martje H L van der Wal; Tiny Jaarsma; Dirk J van Veldhuisen
Non-compliance in patients with heart failure; how can we manage it?
European journal of heart failure 2005;7(1):5-17.
2004: Isabelle C Van Gelder; Michiel Rienstra; Maarten P van den Berg; Dirk J van Veldhuisen
Rate control in atrial fibrillation.
Journal of the American College of Cardiology 2004;44(12):2417-8; author reply 2418-9.
2004: Michiel Rienstra; Vincent E Hagens; Dirk J van Veldhuisen; Hans A Bosker; Jan G P Tijssen; Otto Kamp; Jelte Bouma; Nic J G M Veeger; Harry J G M Crijns; Isabelle C Van Gelder
Clinical characteristics of persistent lone atrial fibrillation in the RACE study.
The American journal of cardiology 2004;94(12):1486-90.
2004: Pieter J de Kam; Adriaan A Voors; Francesco Fici; Dirk J van Veldhuisen; Wiek H van Gilst
The revised role of ACE-inhibition after myocardial infarction in the thrombolytic/primary PCI era.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(4):161-8.
2004: Richard P E van Dokkum; Wouter B A Eijkelkamp; Alex C A Kluppel; Robert H Henning; Harry van Goor; Marin Citgez; Willemijn A K M Windt; Dirk J van Veldhuisen; Pieter A de Graeff; Dick De Zeeuw
Myocardial infarction enhances progressive renal damage in an experimental model for cardio-renal interaction.
Journal of the American Society of Nephrology : JASN 2004;15(12):3103-10.
2004: Tiny Jaarsma; B Tan; R J Bos; Dirk J van Veldhuisen
Heart failure clinics in the Netherlands in 2003.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology 2004;3(4):271-4.
2004: peter van der meer; Erik Lipsic; Robert H Henning; Rudolf A de Boer; Albert J H Suurmeijer; Dirk J van Veldhuisen; Wiek H van Gilst
Erythropoietin improves left ventricular function and coronary flow in an experimental model of ischemia-reperfusion injury.
European journal of heart failure 2004;6(7):853-9.
2004: Folkert Asselbergs; Gilles F H Diercks; Hans L Hillege; Ad J van Boven; Wilbert M T Janssen; Adriaan A Voors; Dick De Zeeuw; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria.
Circulation 2004;110(18):2809-16.
2004: Jochem Hogenhuis; Tiny Jaarsma; Adriaan A Voors; Dirk J van Veldhuisen
BNP and functional status in heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(6):507; author reply 509.
2004: Ruud M A van de Wal; Adriaan A Voors; H W M Plokker; Wiek H van Gilst; Dirk J van Veldhuisen
New pharmacological strategies in chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(6):491-501.
2004: Joost P van Melle; Hendrik Buikema; Maarten P van den Berg; Azuwerus van Buiten; Dirk J van Veldhuisen; Piet W Boonstra; Wiek H van Gilst
Sertraline causes strong coronary vasodilation: possible relevance for cardioprotection by selective serotonin reuptake inhibitors.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(6):441-7.
2004: Riemer H J A Slart; Jeroen J Bax; Wim J Sluiter; Dirk J van Veldhuisen; Pieter L Jager
Added value of attenuation-corrected Tc-99m tetrofosmin SPECT for the detection of myocardial viability: comparison with FDG SPECT.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 2004;11(6):689-96.
2004: Joost P van Melle; Peter de Jonge; Titia A Spijkerman; Jan G P Tijssen; Johan Ormel; Dirk J van Veldhuisen; Rob H S van den Brink; Maarten P van den Berg
Prognostic association of depression following myocardial infarction with mortality and cardiovascular events: a meta-analysis.
Psychosomatic medicine 2004;66(6):814-22.
2004: Bas A Schoonderwoerd; Jannie Ausma; Harry J G M Crijns; Dirk J van Veldhuisen; Engbert H Blaauw; Isabelle C Van Gelder
Atrial ultrastructural changes during experimental atrial tachycardia depend on high ventricular rate.
Journal of cardiovascular electrophysiology 2004;15(10):1167-74.
2004: Erik Lipsic; peter van der meer; Robert H Henning; Albert J H Suurmeijer; Kristien M Boddeus; Dirk J van Veldhuisen; Wiek H van Gilst; Regien G Schoemaker
Timing of erythropoietin treatment for cardioprotection in ischemia/reperfusion.
Journal of cardiovascular pharmacology 2004;44(4):473-9.
2004: Rudolf A de Boer; Saraswati Pokharel; Markus Flesch; Derk A van Kampen; Albert J H Suurmeijer; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen; Yigal M Pinto
Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27.
Journal of molecular medicine (Berlin, Germany) 2004;82(10):678-87.
2004: Johan Brügemann; Klaas Postema; Isabelle C Van Gelder; M H Oosterwijk; Dirk J van Veldhuisen
[Cardiac rehabilitation in patients with a congenital heart disease, an implantable cardioverter defibrillator or chronic heart failure].
Nederlands tijdschrift voor geneeskunde 2004;148(37):1809-15.
2004: Adriaan A Voors; Peter P van Geel; Margreeth Oosterga; Hendrik Buikema; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular effects of quinapril completely depend on ACE insertion/deletion polymorphism.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(3):130-4.
2004: Maarten P van den Berg; Trudeke Van Noord; Jan Brouwer; Jaap Haaksma; Dirk J van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder
Clustering of RR intervals predicts effective electrical cardioversion for atrial fibrillation.
Journal of cardiovascular electrophysiology 2004;15(9):1027-33.
2004: René A Tio; Eng S Tan; Gillian A J Jessurun; Nic J G M Veeger; Pieter L Jager; Riemer H J A Slart; Richard M de Jong; Jan Pruim; Geke A P Hospers; Antoon T M Willemsen; Mike J L de Jongste; Ad J van Boven; Dirk J van Veldhuisen; Felix Zijlstra
PET for evaluation of differential myocardial perfusion dynamics after VEGF gene therapy and laser therapy in end-stage coronary artery disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(9):1437-43.
2004: Vincent E Hagens; Karin M Vermeulen; Elisabeth M TenVergert; Dirk J van Veldhuisen; Hans A Bosker; Otto Kamp; J Herre Kingma; Jan G P Tijssen; Harry J G M Crijns; Isabelle C Van Gelder
Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation--results from the RAte Control versus Electrical cardioversion (RACE) study.
European heart journal 2004;25(17):1542-9.
2004: Maarten P van den Berg; Isabelle C Van Gelder; Dirk J van Veldhuisen
Depletion of atrial natriuretic peptide during longstanding atrial fibrillation.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2004;6(5):433-7.
2004: Pim van der Harst; Adriaan A Voors; Dirk J van Veldhuisen
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
The New England journal of medicine 2004;351(7):714-7; author reply 714-7.
2004: Bas A Schoonderwoerd; Harry J G M Crijns; Dirk J van Veldhuisen; Frans Boomsma; Maarten P van den Berg; Klaas J Bel; Isabelle C Van Gelder
Atrial natriuretic peptides during experimental atrial tachycardia: role of developing tachycardiomyopathy.
Journal of cardiovascular electrophysiology 2004;15(8):927-32.
2004: Stefan H J Monnink; René A Tio; Ad J van Boven; Wiek H van Gilst; Dirk J van Veldhuisen
The role of coronary endothelial function testing in patients suspected for angina pectoris.
International journal of cardiology 2004;96(2):123-9.
2004: Tom D J Smilde; Hans L Hillege; Adriaan A Voors; Peter H J M Dunselman; Dirk J van Veldhuisen
Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction.
The American journal of cardiology 2004;94(2):240-3.
2004: peter van der meer; Adriaan A Voors; Erik Lipsic; Tom D J Smilde; Wiek H van Gilst; Dirk J van Veldhuisen
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure.
Journal of the American College of Cardiology 2004;44(1):63-7.
2004: Tom D J Smilde; Hans L Hillege; gerjan navis; Frans Boomsma; Dick de Zeeuw; Dirk J van Veldhuisen
Impaired renal function in patients with ischemic and nonischemic chronic heart failure: association with neurohormonal activation and survival.
American heart journal 2004;148(1):165-72.
2004: Trudeke Van Noord; Robert G Tieleman; Hans A Bosker; Tsjerk Kingma; Dirk J van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder
Beta-blockers prevent subacute recurrences of persistent atrial fibrillation only in patients with hypertension.
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2004;6(4):343-50.
2004: Ronnie Willenheimer; Erland Erdmann; Ferenc Follath; Henry Krum; Piotr Ponikowski; Bernard Silke; Dirk J van Veldhuisen; Louis Van De Ven; Patricia Verkenne; Philippe Lechat
Comparison of treatment initiation with bisoprolol vs. enalapril in chronic heart failure patients: rationale and design of CIBIS-III.
European journal of heart failure 2004;6(4):493-500.
2004: Patrick J Perik; Maarten P van den Berg; Elisabeth G E de Vries; Dirk J van Veldhuisen
Experimental animal model for anthracycline-induced heart failure.
European journal of heart failure 2004;6(4):375-6.
2004: Bart Westendorp; Regien G Schoemaker; Hendrik Buikema; Dick De Zeeuw; Dirk J van Veldhuisen; Wiek H van Gilst
Dietary sodium restriction specifically potentiates left ventricular ACE inhibition by zofenopril, and is associated with attenuated hypertrophic response in rats with myocardial infarction.
Journal of the renin-angiotensin-aldosterone system : JRAAS 2004;5(1):27-32.
2004: Tiny Jaarsma; Martje H L van der Wal; Jochem Hogenhuis; Ivonne Lesman; Marie Louise Luttik; Nic J G M Veeger; Dirk J van Veldhuisen
Design and methodology of the COACH study: a multicenter randomised Coordinating study evaluating Outcomes of Advising and Counselling in Heart failure.
European journal of heart failure 2004;6(2):227-33.
2004: Pim van der Harst; Adriaan A Voors; Dirk J van Veldhuisen
Short-term statin therapy and cardiac function and symptoms in patients with idiopathic dilated cardiomyopathy.
Circulation 2004;109(5):e34; author reply e34.
2004: peter van der meer; Adriaan A Voors; Erik Lipsic; Wiek H van Gilst; Dirk J van Veldhuisen
Erythropoietin in cardiovascular diseases.
European heart journal 2004;25(4):285-91.
2004: Ans C P Wiesfeld; Eng S Tan; Dirk J van Veldhuisen; Harry J G M Crijns; Isabelle C Van Gelder
Radiofrequency ablation of atrial fibrillation.
International journal of cardiology 2004;93(2-3):231-7.
2004: Folkert Asselbergs; Rudolf A de Boer; Gilles F H Diercks; Bas Langeveld; René A Tio; Paul E de Jong; Dirk J van Veldhuisen; Wiek H van Gilst
Vascular endothelial growth factor: the link between cardiovascular risk factors and microalbuminuria?
International journal of cardiology 2004;93(2-3):211-5.
2004: Anho Liem; Ad J van Boven; Nic J G M Veeger; A J Withagen; R M Robles de Medina; Jan G P Tijssen; Dirk J van Veldhuisen
Efficacy of folic acid when added to statin therapy in patients with hypercholesterolemia following acute myocardial infarction: a randomised pilot trial.
International journal of cardiology 2004;93(2-3):175-9.
2004: Riemer H J A Slart; Jeroen J Bax; Richard M de Jong; Jaep de Boer; Hildo J Lamb; Piet H Mook; Antoon T M Willemsen; Willem Vaalburg; Dirk J van Veldhuisen; Pieter L Jager
Comparison of gated PET with MRI for evaluation of left ventricular function in patients with coronary artery disease.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2004;45(2):176-82.
2004: Riemer H J A Slart; Lieke Poot; D Albertus Piers; Dirk J van Veldhuisen; K Nichols; Pieter L Jager
Gated blood-pool SPECT automated versus manual left ventricular function calculations.
Nuclear medicine communications 2004;25(1):75-80.
2003: Paul L van Haelst; Anho Liem; Ad J van Boven; Nic J G M Veeger; Dirk J van Veldhuisen; J W Cohen Tervaert; Rijk O B Gans; Felix Zijlstra
Usefulness of elevated neopterin and C-reactive protein levels in predicting cardiovascular events in patients with non-Q-wave myocardial infarction.
The American journal of cardiology 2003;92(10):1201-3.
2003: Riemer H J A Slart; Tjin H Que; Dirk J van Veldhuisen; Lieke Poot; Paul K Blanksma; D Albertus Piers; Pieter L Jager
Effect of attenuation correction on the interpretation of 99mTc-sestamibi myocardial perfusion scintigraphy: the impact of 1 year's experience.
European journal of nuclear medicine and molecular imaging 2003;30(11):1505-9.
2003: Riemer H J A Slart; Lieke Poot; D Albertus Piers; Dirk J van Veldhuisen; Pieter L Jager
Evaluation of right ventricular function by NuSMUGA software: gated blood-pool SPECT vs. first-pass radionuclide angiography.
The international journal of cardiovascular imaging 2003;19(5):401-7.
2003: peter van der meer; Wiek H van Gilst; Dirk J van Veldhuisen
Anemia and congestive heart failure.
Circulation 2003;108(6):e41-2; author reply e41-2.
2003: Hazel L White; Rudolf A de Boer; Azhar Maqbool; Darren Greenwood; Dirk J van Veldhuisen; Richard J Cuthbert; Stephen G Ball; Alistair Hall; Anthony J Balmforth
An evaluation of the beta-1 adrenergic receptor Arg389Gly polymorphism in individuals with heart failure: a MERIT-HF sub-study.
European journal of heart failure 2003;5(4):463-8.
2003: Anho Liem; J Wouter Jukema; Dirk J van Veldhuisen
Secondary prevention in coronary heart disease patients with low HDL: which options do we have?
International journal of cardiology 2003;90(1):15-21.
2003: Anho Liem; Giny H Reynierse-Buitenwerf; Aeilko H Zwinderman; J Wouter Jukema; Dirk J van Veldhuisen
Secondary prevention with folic acid: effects on clinical outcomes.
Journal of the American College of Cardiology 2003;41(12):2105-13.
2003: Rudolf A de Boer; Yigal M Pinto; Dirk J van Veldhuisen
The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities.
Microcirculation (New York, N.Y. : 1994) 2003;10(2):113-26.
2003: Maarten P van den Berg; Geert Tjeerdsma; Johan D Lefrandt; Andries J Smit; Anton H van den Meiracker; Arie M Van Roon; Frans Boomsma; Dirk J van Veldhuisen
Effect of lower body negative pressure in patients with mild congestive heart failure.
The American journal of cardiology 2003;91(6):759-62.
2003: Hans L Hillege; Wiek H van Gilst; Dirk J van Veldhuisen; gerjan navis; Diederick Grobbee; Pieter A de Graeff; Dick De Zeeuw
Accelerated decline and prognostic impact of renal function after myocardial infarction and the benefits of ACE inhibition: the CATS randomized trial.
European heart journal 2003;24(5):412-20.
2003: Jean-Sébastien Hulot; Michel Cucherat; Andrew Charlesworth; Dirk J van Veldhuisen; Jean-Christophe Corvol; Alain Mallet; Jean-Pierre Boissel; John Hampton; Philippe Lechat
Planning and monitoring of placebo-controlled survival trials: comparison of the triangular test with usual interim analyses methods.
British journal of clinical pharmacology 2003;55(3):299-306.
2003: Albert J H Suurmeijer; Sophie Clément; Arianna Francesconi; Leonardo Bocchi; Annalisa Angelini; Dirk J van Veldhuisen; Luigi Giusto Spagnoli; Giulio Gabbiani; Augusto Orlandi
Alpha-actin isoform distribution in normal and failing human heart: a morphological, morphometric, and biochemical study.
The Journal of pathology 2003;199(3):387-97.
2003: Richard M de Jong; Paul K Blanksma; Jan Hein Cornel; Ad F M van den Heuvel; Hans-Marc J Siebelink; Willem Vaalburg; Dirk J van Veldhuisen
Endothelial dysfunction and reduced myocardial perfusion reserve in heart failure secondary to coronary artery disease.
The American journal of cardiology 2003;91(4):497-500.
2003: Rudolf A de Boer; Yigal M Pinto; Albert J H Suurmeijer; Saraswati Pokharel; Egbert Scholtens; Michael Humler; Juan M Saavedra; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen
Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction.
Cardiovascular research 2003;57(2):434-42.
2003: Dirk J van Veldhuisen; Wiek H van Gilst
The pharmacological management of heart failure: too many treatments?
European journal of heart failure 2003;5(1):5-8.
2002: Anho Liem; Ad J van Boven; Nic J G M Veeger; A J Withagen; R M Robles de Medina; Jan G P Tijssen; Dirk J van Veldhuisen
Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial.
European heart journal 2002;23(24):1931-7.
2002: Geert Tjeerdsma; Rudolf A de Boer; Frans Boomsma; Maarten P van den Berg; Yigal M Pinto; Dirk J van Veldhuisen
Rapid bedside measurement of brain natriuretic peptide in patients with chronic heart failure.
International journal of cardiology 2002;86(2-3):143-9; discussion 149-52.
2002: Marcelo C Shibata; Marcus Flather; Michael Böhm; Josef Borbola; Alain Cohen-Solal; Daniel Dumitrascu; Roberto Ferrari; Philippe Lechat; Alexander Parkhomenko; Jordi Soler-Soler; Luigi Tavazzi; Jirí Toman; Dirk J van Veldhuisen; Andrew J S Coats; Philip A Poole-Wilson
Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.
International journal of cardiology 2002;86(1):77-85.
2002: Maarten P van den Berg; Isabelle C Van Gelder; Dirk J van Veldhuisen
Impact of atrial fibrillation on mortality in patients with chronic heart failure.
European journal of heart failure 2002;4(5):571-5.
2002: Hans L Hillege; Vaclav Fidler; Gilles F H Diercks; Wiek H van Gilst; Dick De Zeeuw; Dirk J van Veldhuisen; Rijk O B Gans; Wilbert M T Janssen; Diederick Grobbee; Paul E de Jong
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population.
Circulation 2002;106(14):1777-82.
2002: J G J Neffke; Igor I Tulevski; Ernst E van der Wall; Arthur A M Wilde; Dirk J van Veldhuisen; Ali Dodge-Khatami; Barbara J M Mulder
ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters.
Heart (British Cardiac Society) 2002;88(3):266-70.
2002: Lodewijk J Wagenaar; Adriaan A Voors; Hendrik Buikema; Azuwerus van Buiten; Rob H Lübeck; Piet W Boonstra; Dirk J van Veldhuisen; Wiek H van Gilst
Functional antagonism of different angiotensin II type I receptor blockers in human arteries.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2002;16(4):311-6.
2002: Wybe Nieuwland; Marike A Berkhuysen; Dirk J van Veldhuisen; Piet Rispens
Individual assessment of intensity-level for exercise training in patients with coronary artery disease is necessary.
International journal of cardiology 2002;84(1):15-20; discussion 20-1.
2002: Martin T Meinardi; Winette T A van der Graaf; Jourik A Gietema; Maarten P van den Berg; Dirk T Sleijfer; E G E de Vries; Jaap Haaksma; Frans Boomsma; Dirk J van Veldhuisen
Evaluation of long term cardiotoxicity after epirubicin containing adjuvant chemotherapy and locoregional radiotherapy for breast cancer using various detection techniques.
Heart (British Cardiac Society) 2002;88(1):81-2.
2002: Ad F M van den Heuvel; Jeroen J Bax; Paul K Blanksma; Willem Vaalburg; Harry J G M Crijns; Dirk J van Veldhuisen
Abnormalities in myocardial contractility, metabolism and perfusion reserve in non-stenotic coronary segments in heart failure patients.
Cardiovascular research 2002;55(1):97-103.
2002: T Jaarsma; Dirk J van Veldhuisen
The optimal "dose" of disease management programs in HF.
Journal of the American College of Cardiology 2002;39(12):2080-1.
2002: Igor I Tulevski; Barbara J M Mulder; Dirk J van Veldhuisen
Utility of a BNP as a marker for RV dysfunction in acute pulmonary embolism.
Journal of the American College of Cardiology 2002;39(12):2080.
2002: Maarten P van den Berg; Dirk J van Veldhuisen
Atrial natriuretic peptide in atrial fibrillation: a protective but time-limited system.
International journal of cardiology 2002;83(3):207-8.
2002: Maarten P van den Berg; Geert Tjeerdsma; Pieter Jan de Kam; Frans Boomsma; Harry J G M Crijns; Dirk J van Veldhuisen
Longstanding atrial fibrillation causes depletion of atrial natriuretic peptide in patients with advanced congestive heart failure.
European journal of heart failure 2002;4(3):255-62.
2002: Rudolf A de Boer; Peter P van Geel; Yigal M Pinto; Albert J H Suurmeijer; Harry J G M Crijns; Wiek H van Gilst; Dirk J van Veldhuisen
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
Journal of cardiovascular pharmacology 2002;39(4):610-9.
2002: Dirk J van Veldhuisen
Low-dose digoxin in patients with heart failure. Less toxic and at least as effective?
Journal of the American College of Cardiology 2002;39(6):954-6.
2002: Igor I Tulevski; Hans Romkes; Ali Dodge-Khatami; Ernst E van der Wall; Maarten Groenink; Dirk J van Veldhuisen; Barbara J M Mulder
Quantitative assessment of the pressure and volume overloaded right ventricle: imaging is a real challenge.
The international journal of cardiovascular imaging 2002;18(1):41-51.
2002: René A Tio; Jan G Grandjean; Albert J H Suurmeijer; Wiek H van Gilst; Dirk J van Veldhuisen; Ad J van Boven
Thoracoscopic monitoring for pericardial application of local drug or gene therapy.
International journal of cardiology 2002;82(2):117-21.
2002: Richard M de Jong; Paul K Blanksma; Aren van Waarde; Dirk J van Veldhuisen
Measurement of myocardial beta-adrenoceptor density in clinical studies: a role for positron emission tomography?
European journal of nuclear medicine and molecular imaging 2002;29(1):88-97.
2001: Bas A Schoonderwoerd; Isabelle C Van Gelder; Dirk J van Veldhuisen; Robert G Tieleman; Jan G Grandjean; Klaas J Bel; Maurits A Allessie; Harry J G M Crijns
Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy.
Journal of cardiovascular electrophysiology 2001;12(12):1404-10.
2001: Igor I Tulevski; Alexander Hirsch; B J Sanson; Hans Romkes; Ernst E van der Wall; Dirk J van Veldhuisen; Harry R Büller; Barbara J M Mulder
Increased brain natriuretic peptide as a marker for right ventricular dysfunction in acute pulmonary embolism.
Thrombosis and haemostasis 2001;86(5):1193-6.
2001: Ad F M van den Heuvel; Paul K Blanksma; Hans-Marc J Siebelink; LM van Wijk; Frans Boomsma; Willem Vaalburg; Harry J G M Crijns; Dirk J van Veldhuisen
Impairment of myocardial blood flow reserve in patients with asymptomatic left ventricular dysfunction: effects of ACE-inhibition with perindopril.
The international journal of cardiovascular imaging 2001;17(5):353-9.
2001: Giovanni Amoroso; Ad J van Boven; Dirk J van Veldhuisen; René A Tio; C P Baljé-Volkers; Anna Sonia Petronio; W van Oeveren
Eptifibatide and abciximab exhibit equivalent antiplatelet efficacy in an experimental model of stenting in both healthy volunteers and patients with coronary artery disease.
Journal of cardiovascular pharmacology 2001;38(4):633-41.
2001: Dirk J van Veldhuisen; P A Poole-Wilson
The underreporting of results and possible mechanisms of 'negative' drug trials in patients with chronic heart failure.
International journal of cardiology 2001;80(1):19-27.
2001: Richard M de Jong; Jan Hein Cornel; Harry J G M Crijns; Dirk J van Veldhuisen
Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy.
European journal of heart failure 2001;3(4):429-36.
2001: Bianca J J M Brundel; Isabelle C Van Gelder; Anton E Tuinenburg; Mirian Wietses; Dirk J van Veldhuisen; Wiek H van Gilst; Harry J G M Crijns; Robert H Henning
Endothelin system in human persistent and paroxysmal atrial fibrillation.
Journal of cardiovascular electrophysiology 2001;12(7):737-42.
2001: Igor I Tulevski; Maarten Groenink; Ernst E van der Wall; Dirk J van Veldhuisen; F Boomsma; Jaap Stoker; Alexander Hirsch; J S Lemkes; Barbara J M Mulder
Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.
Heart (British Cardiac Society) 2001;86(1):27-30.
2001: Martin T Meinardi; Dirk J van Veldhuisen; Jourik A Gietema; W V Dolsma; Frans Boomsma; Maarten P van den Berg; Corine P Volkers; Jaap Haaksma; Elisabeth G E de Vries; Dirk T Sleijfer; Winette T A van der Graaf
Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(10):2746-53.
2001: Geert Tjeerdsma; LM van Wijk; G P Molhoek; Frans Boomsma; Jaap Haaksma; Dirk J van Veldhuisen
Autonomic and hemodynamic effects of a new selective dopamine agonist, CHF1035, in patients with chronic heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2001;15(2):139-45.
2001: Rudolf A de Boer; R H Henning; Albert J H Suurmeijer; Yigal M Pinto; E Olthof; J H Kirkels; Wiek H van Gilst; Harry J G M Crijns; Dirk J van Veldhuisen
Early expression of natriuretic peptides and SERCA in mild heart failure: association with severity of the disease.
International journal of cardiology 2001;78(1):5-12.
2001: Ad F M van den Heuvel; Peter H J M Dunselman; T Kingma; P Verhorst; Frans Boomsma; Wiek H van Gilst; Dirk J van Veldhuisen
Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade.
Journal of the American College of Cardiology 2001;37(2):470-4.
2001: Geert Tjeerdsma; B M Szabó; LM van Wijk; Jan Brouwer; René A Tio; Harry J G M Crijns; Dirk J van Veldhuisen
Autonomic dysfunction in patients with mild heart failure and coronary artery disease and the effects of add-on beta-blockade.
European journal of heart failure 2001;3(1):33-9.
2000: Rudolf A de Boer; Dirk J van Veldhuisen; J van der Wijk; R M Brouwer; N de Jonge; Gregory M. Cole; Albert J H Suurmeijer
Additional use of immunostaining for active caspase 3 and cleaved actin and PARP fragments to detect apoptosis in patients with chronic heart failure.
Journal of cardiac failure 2000;6(4):330-7.
2000: Martin T Meinardi; Jourik A Gietema; Dirk J van Veldhuisen; Winette T A van der Graaf; Elisabeth G E de Vries; Dirk T Sleijfer
Long-term chemotherapy-related cardiovascular morbidity.
Cancer treatment reviews 2000;26(6):429-47.
2000: Pieter J de Kam; Adriaan A Voors; Maarten P van den Berg; Dirk J van Veldhuisen; Jan Brouwer; Harry J G M Crijns; C Borghi; E Ambrosioni; Judith S Hochman; T H LeJemtel; J Herre Kingma; M S Sutton; Wiek H van Gilst
Effect of very early angiotensin-converting enzyme inhibition on left ventricular dilation after myocardial infarction in patients receiving thrombolysis: results of a meta-analysis of 845 patients. FAMIS, CAPTIN and CATS Investigators.
Journal of the American College of Cardiology 2000;36(7):2047-53.
2000: Frans Boomsma; Pieter J de Kam; Geert Tjeerdsma; Anton H van den Meiracker; Dirk J van Veldhuisen
Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure.
European heart journal 2000;21(22):1859-63.
2000: Harry J G M Crijns; Geert Tjeerdsma; Pieter J de Kam; Frans Boomsma; Isabelle C Van Gelder; Maarten P van den Berg; Dirk J van Veldhuisen
Prognostic value of the presence and development of atrial fibrillation in patients with advanced chronic heart failure.
European heart journal 2000;21(15):1238-45.
2000: Hans L Hillege; A R Girbes; Pieter J de Kam; Frans Boomsma; Dick De Zeeuw; Andrew Charlesworth; John R Hampton; Dirk J van Veldhuisen
Renal function, neurohormonal activation, and survival in patients with chronic heart failure.
Circulation 2000;102(2):203-10.
2000: Wybe Nieuwland; Marike A Berkhuysen; Dirk J van Veldhuisen; Johan Brügemann; M L Landsman; Eric van Sonderen; KI Lie; Harry J G M Crijns; Piet Rispens
Differential effects of high-frequency versus low-frequency exercise training in rehabilitation of patients with coronary artery disease.
Journal of the American College of Cardiology 2000;36(1):202-7.
2000: Y S Tuininga; Ans C P Wiesfeld; Dirk J van Veldhuisen; Isabelle C Van Gelder; Harry J G M Crijns
Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction.
Journal of cardiac failure 2000;6(2):77-9.
2000: AC Teisman; Hendrik Buikema; Dirk J van Veldhuisen; Dick De Zeeuw; Wiek H van Gilst
Direct vasodilating effects of the new dopaminergic agonist Z1046 in human arteries.
Journal of cardiovascular pharmacology 2000;35(4):581-5.
2000: Martin T Meinardi; Jourik A Gietema; Winette T A van der Graaf; Dirk J van Veldhuisen; M A Runne; Wim J Sluiter; Elisabeth G E de Vries; P B Willemse; Nanno H Mulder; Maarten P van den Berg; Heimen Schraffordt Koops; Dirk T Sleijfer
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1725-32.
2000: Geert Tjeerdsma; Jan Brouwer; Pieter J de Kam; Jaap Haaksma; Harry J G M Crijns; Dirk J van Veldhuisen
Effect of mibefradil on heart rate variability in patients with chronic heart failure.
International journal of cardiology 2000;73(1):55-60.
2000: AC Teisman; Dirk J van Veldhuisen; Frans Boomsma; Pieter J de Kam; Geert Tjeerdsma; Yigal M Pinto; Dick De Zeeuw; Wiek H van Gilst
Chronic beta-blocker treatment in patients with advanced heart failure. Effects on neurohormones.
International journal of cardiology 2000;73(1):7-12; discussion 13-4.
2000: Rutger L Anthonio; Dirk J van Veldhuisen; A Breekland; Harry J G M Crijns; Wiek H van Gilst
Beta-blocker titration failure is independent of severity of heart failure.
The American journal of cardiology 2000;85(4):509-12, A11.
2000: RJ de Vries; Dirk J van Veldhuisen; Peter H J M Dunselman
Efficacy and safety of calcium channel blockers in heart failure: focus on recent trials with second-generation dihydropyridines.
American heart journal 2000;139(2 Pt 1):185-94.
2000: Rutger L Anthonio; O E Brodde; Dirk J van Veldhuisen; Egbert Scholtens; Harry J G M Crijns; Wiek H van Gilst
Beta-adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of beta1-adrenoceptor density.
International journal of cardiology 2000;72(2):137-41.
2000: AC Teisman; Ben H C Westerink; Dirk J van Veldhuisen; Egbert Scholtens; Dick De Zeeuw; Wiek H van Gilst
Direct interaction between the sympathetic and renin-angiotensin system in myocardial tissue: a microdialysis study in anaesthetised rats.
Journal of the autonomic nervous system 2000;78(2-3):117-21.
2000: Ad F M van den Heuvel; Dirk J van Veldhuisen; Ernst E van der Wall; Paul K Blanksma; Hans-Marc J Siebelink; Willem Vaalburg; Wiek H van Gilst; Harry J G M Crijns
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.
Journal of the American College of Cardiology 2000;35(1):19-28.
1999: MH Brouwer; Maarten P van den Berg; Joost M A A van der Maaten; Johan Brügemann; HE Mungroop; Dirk J van Veldhuisen
[Partial left ventriculectomy (Batista procedure) for the treatment of terminal heart failure after rejection for heart transplantation].
Nederlands tijdschrift voor geneeskunde 1999;143(46):2319-24.
1999: Dirk J van Veldhuisen; Maarten P van den Berg
The electrocardiogram in traumatic right atrial rupture.
International journal of cardiology 1999;71(2):179-80.
1999: Yigal M Pinto; Peter P van Geel; H Alkfaji; Dirk J van Veldhuisen; Wiek H van Gilst
Dosing of ACE inhibitors in left ventricular dysfunction: does current clinical dosing provide optimal benefit?
Journal of cardiovascular pharmacology 1999;34 Suppl 1():S13-7.
1999: Martin T Meinardi; Winette T A van der Graaf; Dirk J van Veldhuisen; Jourik A Gietema; Elisabeth G E de Vries; Dirk T Sleijfer
Detection of anthracycline-induced cardiotoxicity.
Cancer treatment reviews 1999;25(4):237-47.
1999: Dirk J van Veldhuisen; Andrew Charlesworth; Harry J G M Crijns; KI Lie; John R Hampton
Differences in drug treatment of chronic heart failure between European countries.
European heart journal 1999;20(9):666-72.
1999: Rutger L Anthonio; Jan Brouwer; P Lechat; Jaap Haaksma; L van der Ven; Dirk J van Veldhuisen; Harry J G M Crijns; Wiek H van Gilst
Different effects of bisoprolol on heart rate in patients with ischemic or idiopathic dilated cardiomyopathy (a 24-hour Holter substudy of the Cardiac Insufficiency Bisoprolol Study [CIBIS]).
The American journal of cardiology 1999;83(8):1286-9, A10.
1999: Geert Tjeerdsma; Martin T Meinardi; Winette T A van der Graaf; Maarten P van den Berg; Nanno H Mulder; Harry J G M Crijns; Elisabeth G E de Vries; Dirk J van Veldhuisen
Early detection of anthracycline induced cardiotoxicity in asymptomatic patients with normal left ventricular systolic function: autonomic versus echocardiographic variables.
Heart (British Cardiac Society) 1999;81(4):419-23.
1999: John R Hampton; Dirk J van Veldhuisen; Alan J Cowley; F X Kleber; Andrew Charlesworth
Achieving appropriate endpoints in heart failure trials: the PRIME-II protocol. The Second Perspective Randomised study of Ibopamine on Mortality and Efficacy.
European journal of heart failure 1999;1(1):89-93.
1998: Dirk J van Veldhuisen; Sabine Genth-Zotz; Jan Brouwer; Frans Boomsma; T Netzer; A J Man In 'T Veld; Yigal M Pinto; KI Lie; Harry J G M Crijns
High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.
Journal of the American College of Cardiology 1998;32(7):1811-8.
1998: Wybe Nieuwland; Marike A Berkhuysen; Dirk J van Veldhuisen; Eric van Sonderen; J W Viersma; KI Lie; Piet Rispens
Impairment of exercise capacity and peak oxygen consumption in patients with mild left ventricular dysfunction and coronary artery disease.
European heart journal 1998;19(11):1688-95.
1998: Geert Tjeerdsma; J Brouwer; Dirk J van Veldhuisen
Images in cardiology. Rapid progression of pericardial malignant mesothelioma.
Heart (British Cardiac Society) 1998;79(6):618.
1998: Anton E Tuinenburg; Dirk J van Veldhuisen; Frans Boomsma; Maarten P van den Berg; Pieter J de Kam; Harry J G M Crijns
Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm.
The American journal of cardiology 1998;81(10):1207-10.
1998: Dirk J van Veldhuisen; Frans Boomsma; Pieter J de Kam; AJ Man in't Veld; Harry J G M Crijns; John R Hampton; KI Lie
Influence of age on neurohormonal activation and prognosis in patients with chronic heart failure.
European heart journal 1998;19(5):753-60.
1998: Maarten P van den Berg; Harry J G M Crijns; Dirk J van Veldhuisen; Isabelle C Van Gelder; Pieter J de Kam; KI Lie
Atrial natriuretic peptide in patients with heart failure and chronic atrial fibrillation: role of duration of atrial fibrillation.
American heart journal 1998;135(2 Pt 1):242-4.
1998: Maarten P van den Berg; Anton E Tuinenburg; Dirk J van Veldhuisen; Pieter J de Kam; Harry J G M Crijns
Cardioversion of atrial fibrillation in the setting of mild to moderate heart failure.
International journal of cardiology 1998;63(1):63-70.
1998: Dirk J van Veldhuisen; Ad F M van den Heuvel; Paul K Blanksma; Harry J G M Crijns
Ischemia and left ventricular dysfunction: a reciprocal relation?
Journal of cardiovascular pharmacology 1998;32 Suppl 1():S46-51.
1998: Rutger L Anthonio; Dirk J van Veldhuisen; Wiek H van Gilst
Left ventricular dilatation after myocardial infarction: ACE inhibitors, beta-blockers, or both?
Journal of cardiovascular pharmacology 1998;32 Suppl 1():S1-8.
1998: Dirk J van Veldhuisen; Wiek H van Gilst; G S Francis
Current insights and new treatment options in heart failure.
Journal of cardiovascular pharmacology 1998;32 Suppl 1():v-vi.
1997: René A Tio; A K L Reyners; Dirk J van Veldhuisen; Maarten P van den Berg; R M Brouwer; Jaap Haaksma; Andries J Smit; H J Crijns
Evidence for differential sympathetic and parasympathetic reinnervation after heart transplantation in humans.
Journal of the autonomic nervous system 1997;67(3):176-83.
1997: RJ de Vries; Dirk J van Veldhuisen; Peter H J M Dunselman; N van der Veer; Harry J G M Crijns
Physiological parameters during the initial stages of cardiopulmonary exercise testing in patients with chronic heart failure. Their value in the assessment of clinical severity and prognosis.
European heart journal 1997;18(12):1921-30.
1997: RJ de Vries; Rutger L Anthonio; Dirk J van Veldhuisen; Egbert Scholtens; Hendrik Buikema; Wiek H van Gilst
Effects of amlodipine on endothelial function in rats with chronic heart failure after experimental myocardial infarction.
Journal of cardiovascular pharmacology 1997;30(5):683-9.
1997: Rutger L Anthonio; Dirk J van Veldhuisen; Egbert Scholtens; C van Bekkum; E de Boer; Wiek H van Gilst
Myocardial infarction with aortic banding. A combined rat model of heart failure.
Japanese heart journal 1997;38(5):697-708.
1997: AC Teisman; Dirk J van Veldhuisen; Egbert Scholtens; W Maselbas; Wiek H van Gilst
Effects of selective dopaminergic receptor stimulation on ventricular remodeling after experimental myocardial infarction in rats.
Journal of cardiac failure 1997;3(3):199-205.
1997: S A van den Broek; Pieter A de Graeff; Dirk J van Veldhuisen; Wiek H van Gilst; Hans L Hillege; H Wesseling; K I Lie
Clinical and neurohumoral differences between spirapril and captopril in mild to moderate chronic congestive heart failure.
Journal of cardiac failure 1997;3(3):165-71.
1997: G A Somsen; B M Szabó; Dirk J van Veldhuisen; P A R de Milliano; C A de Groot; Kong I Lie
Comparison between iodine 123 metaiodobenzylguanidine scintigraphy and heart rate variability for the assessment of cardiac sympathetic activity in mild to moderate heart failure.
American heart journal 1997;134(3):456-8.
1997: Ad F M van den Heuvel; Wiek H van Gilst; Dirk J van Veldhuisen; RJ de Vries; Peter H J M Dunselman; J Herre Kingma
Long-term anti-ischemic effects of angiotensin-converting enzyme inhibition in patients after myocardial infarction. The Captopril and Thrombolysis Study (CATS) Investigators.
Journal of the American College of Cardiology 1997;30(2):400-5.
1997: B M Szabó; Dirk J van Veldhuisen; Pieter A de Graeff; KI Lie
Alterations in the prognosis of chronic heart failure: an overview of the major mortality trials.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1997;11(3):427-34.
1997: Hendrik Buikema; Dirk J van Veldhuisen; H Hegeman; Wiek H van Gilst
Early pharmacologic intervention may prevent the deterioration in endothelial function after experimental myocardial infarction in rats: effects of ibopamine and captopril.
Journal of cardiac failure 1997;3(2):125-32.
1997: A T Gosselink; Dirk J van Veldhuisen; Harry J G M Crijns
When, and when not, to use digoxin in the elderly.
Drugs & aging 1997;10(6):411-20.
1997: B M Szabó; Dirk J van Veldhuisen; RB van Dijk; A Lahiri; V Mitrovic; K Stolzenburg; Jan Brouwer; KI Lie
Hemodynamic and autonomic effects of intravenous saterinone in patients with chronic heart failure.
Journal of cardiovascular pharmacology 1997;29(5):618-23.
1997: Harry J G M Crijns; Maarten P van den Berg; Isabelle C Van Gelder; Dirk J van Veldhuisen
Management of atrial fibrillation in the setting of heart failure.
European heart journal 1997;18 Suppl C():C45-9.
1997: B M Szabó; Dirk J van Veldhuisen; N van der Veer; Jan Brouwer; Pieter A de Graeff; Harry J G M Crijns
Prognostic value of heart rate variability in chronic congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy.
The American journal of cardiology 1997;79(7):978-80.
1997: Frans Boomsma; Dirk J van Veldhuisen; Pieter J de Kam; AJ Man in't Veld; Arend Mosterd; K I Lie; Maarten A D H Schalekamp
Plasma semicarbazide-sensitive amine oxidase is elevated in patients with congestive heart failure.
Cardiovascular research 1997;33(2):387-91.
1996: A R Girbes; A G Lieverse; Andries J Smit; Dirk J van Veldhuisen; Jan H Zwaveling; Sybren Meijer; WD Reitsma
Lack of specific renal haemodynamic effects of different doses of dopamine after infrarenal aortic surgery.
British journal of anaesthesia 1996;77(6):753-7.
1996: Jan Brouwer; Dirk J van Veldhuisen; A J Man in 't Veld; Jaap Haaksma; W A Dijk; K R Visser; Frans Boomsma; P H Dunselman
Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure. The Dutch Ibopamine Multicenter Trial Study Group.
Journal of the American College of Cardiology 1996;28(5):1183-9.
1996: Dirk J van Veldhuisen; Pieter A de Graeff; W J Remme; K I Lie
Value of digoxin in heart failure and sinus rhythm: new features of an old drug?
Journal of the American College of Cardiology 1996;28(4):813-9.
1996: B M Szabó; Dirk J van Veldhuisen; P H van der Burgh; J Kruik; A R Girbes; K I Lie
Clinical and autonomic effects of ibopamine as adjunct to angiotensin-converting enzyme inhibitors in chronic heart failure.
Journal of cardiac failure 1996;2(3):185-92.
1996: J van Wijngaarden; Dirk J van Veldhuisen; Pieter A de Graeff
[Treatment of Angina pectoris using nitrates].
Nederlands tijdschrift voor geneeskunde 1996;140(15):819-22.
1996: RJ de Vries; Peter H J M Dunselman; U G Chin Kon Sung; Dirk J van Veldhuisen; H M Corbeij; Wiek H van Gilst; K I Lie
Effects of lacidipine on peak oxygen consumption, neurohormones and invasive haemodynamics in patients with mild to moderate chronic heart failure.
Heart (British Cardiac Society) 1996;75(2):159-64.
1996: Yigal M Pinto; Dirk J van Veldhuisen; R T Tjon-Ka-Jie; G Rooks; T Netzer; K I Lie
Dose-finding study of imidapril, a novel angiotensin converting enzyme inhibitor, in patients with stable chronic heart failure.
European journal of clinical pharmacology 1996;50(4):265-8.
1996: E W van den Toren; Dirk J van Veldhuisen; A van Bruggen; S A van den Broek; Wiek H van Gilst; K I Lie
Acute hemodynamic and long-term clinical effects of isradipine in patients with coronary artery disease and chronic heart failure. A double-blind, placebo-controlled study.
International journal of cardiology 1996;53(1):37-43.
1995: RJ de Vries; M Queré; D J Lok; P Sijbring; jeroen bucx; Dirk J van Veldhuisen; Peter H J M Dunselman
Comparison of effects on peak oxygen consumption, quality of life, and neurohormones of felodipine and enalapril in patients with congestive heart failure.
The American journal of cardiology 1995;76(17):1253-8.
1995: Maarten P van den Berg; H J Crijns; Dirk J van Veldhuisen; N Griep; Pieter J de Kam; K I Lie
Effects of lisinopril in patients with heart failure and chronic atrial fibrillation.
Journal of cardiac failure 1995;1(5):355-63.
1995: Jan Brouwer; J W Viersma; Dirk J van Veldhuisen; A J Man in 't Veld; P Sijbring; Jaap Haaksma; W A Dijk; K I Lie
Usefulness of heart rate variability in predicting drug efficacy (metoprolol vs diltiazem) in patients with stable angina pectoris.
The American journal of cardiology 1995;76(11):759-63.
1995: B M Szabó; Dirk J van Veldhuisen; Jan Brouwer; Jaap Haaksma; K I Lie
Relation between severity of disease and impairment of heart rate variability parameters in patients with chronic congestive heart failure secondary to coronary artery disease.
The American journal of cardiology 1995;76(10):713-6.
1995: Jan Brouwer; Dirk J van Veldhuisen; A J Man in 't Veld; P H Dunselman; Frans Boomsma; Jaap Haaksma; K I Lie
Heart rate variability in patients with mild to moderate heart failure: effects of neurohormonal modulation by digoxin and ibopamine. The Dutch Ibopamine Multicenter Trial (DIMT) Study Group.
Journal of the American College of Cardiology 1995;26(4):983-90.
1995: Dirk J van Veldhuisen; O E Brodde; Wiek H van Gilst; C Schulze; H Hegeman; Rutger L Anthonio; Egbert Scholtens; Pieter A de Graeff; H Wesseling; K I Lie
Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
Cardiovascular research 1995;30(3):386-93.
1995: B M Szabó; Harry J G M Crijns; A C Wiesfeld; Dirk J van Veldhuisen; H L Hillege; K I Lie
Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade.
American heart journal 1995;130(2):281-6.
1995: A G Lieverse; A R Girbes; Dirk J van Veldhuisen; Andries J Smit; Jan G Zijlstra; Sybren Meijer; K I Lie; WD Reitsma
The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.
European heart journal 1995;16(7):937-42.
1995: Andries J Smit; A G Lieverse; Dirk J van Veldhuisen; A R Girbes
Dopaminergic modulation of physiological and pathological neurohumoral activation in man.
Hypertension research : official journal of the Japanese Society of Hypertension 1995;18 Suppl 1():S107-11.
1995: Dirk J van Veldhuisen; Jan Brouwer; A J Man in 't Veld; Peter H J M Dunselman; Frans Boomsma; K I Lie
Progression of mild untreated heart failure during six months follow-up and clinical and neurohumoral effects of ibopamine and digoxin as monotherapy. DIMT Study Group. Dutch Ibopamine Multicenter Trial.
The American journal of cardiology 1995;75(12):796-800.
1995: A G Lieverse; Dirk J van Veldhuisen; Andries J Smit; Jan G Zijlstra; Sybren Meijer; WD Reitsma; K I Lie; A R Girbes
Renal and systemic hemodynamic effects of ibopamine in patients with mild to moderate congestive heart failure.
Journal of cardiovascular pharmacology 1995;25(3):361-7.
1995: Y S Tuininga; Dirk J van Veldhuisen; Harry J G M Crijns; S A van den Broek; Jan Brouwer; Jaap Haaksma; A J Man in 't Veld; K I Lie
Exploratory study of the effects of single doses of isomazole on hemodynamics and heart rate variability parameters in chronic heart failure.
Journal of cardiovascular pharmacology 1995;25(1):81-6.
1995: S A van den Broek; Pieter A de Graeff; Andries J Smit; A R Girbes; Wiek H van Gilst; H Hillege; Dirk J van Veldhuisen; H Wesseling; K I Lie
Effects of spirapril and captopril on regional blood flow in chronic congestive heart failure: a comparison between a short- and a long-acting angiotensin-converting enzyme inhibitor.
Journal of cardiovascular pharmacology 1995;25(1):105-12.
1995: A R Girbes; A R Milner; B V McCloskey; Jan H Zwaveling; Dirk J van Veldhuisen; Jan G Zijlstra; K I Lie
Oral ibopamine substitution in patients with intravenous dopamine dependence.
Cardiology 1995;86(5):391-5.
1994: RJ de Vries; Peter H J M Dunselman; Dirk J van Veldhuisen; Ad F M van den Heuvel; RP Wielenga; K I Lie
Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris.
The American journal of cardiology 1994;74(12):1201-6.
1994: Y S Tuininga; Dirk J van Veldhuisen; Jan Brouwer; Jaap Haaksma; Harry J G M Crijns; A J Man in't Veld; K I Lie
Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment.
British heart journal 1994;72(6):509-13.
1994: B M Szabó; Dirk J van Veldhuisen; Harry J G M Crijns; A C Wiesfeld; H L Hillege; K I Lie
Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure.
European heart journal 1994;15(7):928-33.
1994: Wiek H van Gilst; Dirk J van Veldhuisen; H Hegeman; Hendrik Buikema; Egbert Scholtens; Pieter A de Graeff; K I Lie
Effect of ibopamine on ventricular remodeling after experimental myocardial infarction: a comparison with captopril.
Journal of cardiovascular pharmacology 1994;24(1):171-4.
1994: E Wout van den Toren; RJ de Vries; M C Portegies; Paul K Blanksma; Wiek H van Gilst; H J Hillege; Dirk J van Veldhuisen; K I Lie
Effect of isradipine and nifedipine on diastolic function in patients with left ventricular dysfunction due to coronary artery disease: a randomized, double-blind, nuclear, stethoscope study.
Journal of cardiovascular pharmacology 1994;23(6):952-8.
1994: Dirk J van Veldhuisen; Wiek H van Gilst; B J de Smet; Pieter A de Graeff; Egbert Scholtens; Hendrik Buikema; A R Girbes; H Wesseling; K I Lie
Neurohumoral and hemodynamic effects of ibopamine in a rat model of chronic myocardial infarction and heart failure.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 1994;8(2):245-50.
1994: J van Wijngaarden; Andries J Smit; Pieter A de Graeff; Wiek H van Gilst; S A van der Broek; Dirk J van Veldhuisen; K I Lie; H Wesseling
Effects of acetylsalicylic acid on peripheral hemodynamics in patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors.
Journal of cardiovascular pharmacology 1994;23(2):240-5.
1993: Hendrik Buikema; Wiek H van Gilst; Dirk J van Veldhuisen; B J de Smet; Egbert Scholtens; K I Lie; H Wesseling
Endothelium dependent relaxation in two different models of chronic heart failure and the effect of ibopamine.
Cardiovascular research 1993;27(12):2118-24.
1993: Dirk J van Veldhuisen; A J Man in 't Veld; Peter H J M Dunselman; D J Lok; H J Dohmen; J C Poortermans; A J Withagen; W H Pasteuning; Jan Brouwer; K I Lie
Double-blind placebo-controlled study of ibopamine and digoxin in patients with mild to moderate heart failure: results of the Dutch Ibopamine Multicenter Trial (DIMT).
Journal of the American College of Cardiology 1993;22(6):1564-73.
1993: Y S Tuininga; Harry J G M Crijns; A C Wiesfeld; Dirk J van Veldhuisen; H L Hillege; K I Lie
Electrocardiographic patterns relative to initiating mechanisms of exercise-induced ventricular tachycardia.
American heart journal 1993;126(2):359-67.
1993: Maarten P van den Berg; Harry J G M Crijns; A T Marcel Gosselink; S A van den Broek; H J Hillege; Dirk J van Veldhuisen; K I Lie
Chronotropic response to exercise in patients with atrial fibrillation: relation to functional state.
British heart journal 1993;70(2):150-3.
1993: S A van den Broek; Dirk J van Veldhuisen; Pieter A de Graeff; Harry J G M Crijns; Wiek H van Gilst; H Hillege; K I Lie
Mode of death in patients with congestive heart failure: comparison between possible candidates for heart transplantation and patients with less advanced disease.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1993;12(3):367-71.
1993: Dirk J van Veldhuisen; A R Girbes; S A van den Broek; Pieter A de Graeff; Wiek H van Gilst; K I Lie
Effects of ibopamine on the increase in plasma norepinephrine levels during exercise in congestive heart failure.
The American journal of cardiology 1993;71(11):992-4.
1993: A R Girbes; C J Kalisvaart; Dirk J van Veldhuisen; E T Tan; Andries J Smit; WD Reitsma; W H Pasteuning
Effects of ibopamine on renal haemodynamics in patients with severe congestive heart failure.
European heart journal 1993;14(2):279-83.
1992: Dirk J van Veldhuisen; A R Girbes; Pieter A de Graeff; K I Lie
Effects of dopaminergic agents on cardiac and renal function in normal man and in patients with congestive heart failure.
International journal of cardiology 1992;37(3):293-300.
1992: A C Wiesfeld; Harry J G M Crijns; Dirk J van Veldhuisen; Wiek H van Gilst; K I Lie
Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.
Clinical cardiology 1992;15(9):689-92.
1992: S A van den Broek; Dirk J van Veldhuisen; Pieter A de Graeff; M L Landsman; H Hillege; K I Lie
Comparison between New York Heart Association classification and peak oxygen consumption in the assessment of functional status and prognosis in patients with mild to moderate chronic congestive heart failure secondary to either ischemic or idiopathic dilated cardiomyopathy.
The American journal of cardiology 1992;70(3):359-63.
1992: A R Girbes; Dirk J van Veldhuisen; René G Grevink; A J Smith; WD Reitsma
Effects of ibopamine on exercise-induced increase in norepinephrine in normal men.
Journal of cardiovascular pharmacology 1992;19(3):371-4.
1991: Dirk J van Veldhuisen; Harry J G M Crijns; A R Girbes; T J Tobé; A C Wiesfeld; K I Lie
Electrophysiologic profile of ibopamine in patients with congestive heart failure and ventricular tachycardia and relation to its effects on hemodynamics and plasma catecholamines.
The American journal of cardiology 1991;68(11):1194-202.
1991: A R Girbes; Dirk J van Veldhuisen; Andries J Smit; A Drent-Bremer; Sybren Meijer; WD Reitsma
Renal and neurohumoral effects of ibopamine and metoclopramide in normal man.
British journal of clinical pharmacology 1991;31(6):701-4.
1991: Dirk J van Veldhuisen; A R Girbes; Harry J G M Crijns; Andries J Smit; Wiek H van Gilst; K I Lie
The oral dopamine agonist, ibopamine, in normal man: effects on rhythm, heart rate, blood pressure and catecholamines.
International journal of clinical pharmacology research 1991;11(3):159-65.
1990: Dirk J van Veldhuisen; H P Hamer; Gustaaf W van Imhoff; H Hollema; K I Lie
Role of echocardiography in the diagnosis of cardiac lymphoma.
American heart journal 1990;119(4):973-7.
1990: Dirk J van Veldhuisen; A R Girbes; Harry J G M Crijns; Andries J Smit; Pieter A de Graeff; K I Lie
Efficacy and safety of ibopamine in congestive heart failure.
Journal of autonomic pharmacology 1990;10 Suppl 1():s115-21.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.